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ABSTRACT
The purpose was to examine the cardiovascular response to an acute bout of
handgrip exercise before and after non-dominant arm exercise training. 19 people
participated in 16 sessions of exercise training and 16 participants acted as controls
(age: 20±1yrs). Blood flow measurements were taken at rest and following 3-min of
forearm occlusion (RHBF) using plethysmography. Pneumotachometer, ECG, and
blood pressure data were continuously collected during three testing conditions
(spontaneous breathing (SB1: 5min), handgrip exercise (0.5hz) at 60%MVC with
50mmHg of pressure on the arm (H60+50mmHg: 5 min), and forearm occlusion (FAO:
3min)). Data were analyzed for respiratory rate, mean R-R interval, standard deviation
of normal RR intervals (SDNN), normalized units of low- (0-0.15 hz) frequency power
(LFnu), and mean arterial pressure (MAP). There was no main effect of group or arm.
There was a main effect of test condition such that respiratory rate
(+3.10±5.40breaths/min), LFnu (+19.06±14.73%), and MAP increased
(+24.51±21.15mmHg) and mean R-R (-247.11±129.70msec) and SDNN (45.16±40.65msec) decreased significantly during H60+50mmHg (non-dominant arm;
p<0.05). Respiratory rate (-0.10±4.84breaths/min), SDNN (-9.50±57.14msec), and
LFnu (-1.64±18.34%) recovered to SB1 levels during. Mean R-R (46.11±106.57msec)
and MAP (16.65±15.84mmHg) remained elevated above SB1 (p<0.05). There were
positive linear associations between forearm circumference and Mean R-R and MAP
during H60+50mmHg; and MAP during FAO. There was a negative linear association
with forearm circumference and Mean R-R during FAO. There was no significant main
effect or interaction with handgrip exercise training on any of the variables. There was a

ix

decrease in vascular resistance during RHBF (0.80±1.08 mmHg/ ml/100ml/min, p<0.05)
in the arm that underwent exercise training. In conclusion, we found elevated MAP
during FAO, which is indicative of significant EPR activity during exercise. Uniquely, we
found linear associations between forearm circumference and the cardiovascular
response to H60+50mmHg and FAO suggesting variation in the predominant
mechanism of cardiovascular control. We did not see an attenuation of cardiovascular
responses to H60+50mmHg and FAO with exercise training. However, we did see a
decrease in forearm vascular resistance during the reactive hyperemia condition in the
exercise-trained arm.

x

CHAPTER 1 INTRODUCTION
In response to the onset of exercise, heart rate and blood pressure rise to
support working tissue. The initiation and magnitude of this response is a consequence
of central and peripheral factors including higher brain center activity (anticipation of
exercise) and mechanical compression and subsequent production of local metabolic
by-products in the working musculature. Information from the higher brain centers and
peripheral sites is received in various regulatory centers of the brain, which contribute to
the modulation of various organs important in the exercise effort.
Arguably the most important regulatory center at the onset of the exercise effort
is the cardiovascular control center located in the medulla oblongata. It is the
cardiovascular control center, which enables rapid modulation of the cardiovascular
system through parasympathetic withdrawal and increased sympathetic activation. The
feedback loop between the local tissues involved in the exercise effort and the
cardiovascular control center is known as the exercise pressor reflex. It is believed that
receptors originating in the exercising skeletal muscle detect movement and the
presence of metabolites released during exercise, and signal the vasoregulatory center
of the brain through specific afferent tracks resulting in an efferent autonomic mediated
responses (Rowell, 1997; Mitchell, Kaufman, Iwamoto, 1983; Thomas, Chavoshan,
Sander, Victor, 1998).
The extent to which afferent information influences the autonomic response is
poorly understood, but appears to have important clinical relevance. Recent literature
suggests that dysfunction in skeletal muscle afferents may contribute to exercise
intolerance in the elderly and those with heart failure (Piepoli, Ponikowski, Clark,
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Banasiak, Capucci, Coats, 1999; Dinenno, Jones, Seals, Tanaka, 1999). Before we
can understand how to intervene in clinically significant changes in EPR, we need to
better understand EPR function during acute exercise in humans and the plasticity of
EPR to exercise training or pharmacology.

This may allow the development of

treatment strategies for clinical populations effected by hypo- or hyperactive EPR.
There are a number of approaches that have been developed to identify the role
of EPR during exercise. The EPR can be broken down into three distinct parts: the
afferent arm of the reflex arc, the efferent arm of the reflex arc, and the end organ
response to neural modulation via EPR.
Models to evaluate the role of EPR during exercise also can be categorized
according to the part (described above) of the EPR from which they derive their
information. The afferent models are considered the most highly controlled approach to
evaluating the role of EPR during exercise, and directly measure afferent neural activity
at the nerve or in the spinal cord. Models employing this technique have been generally
performed on animals.
Alternately, direct nerve recordings from the efferent arm of the reflex arc can
also be recorded and will be termed efferent models. Although experimental control
over central command is less complete in these models it is possible to perform efferent
measurement techniques in both animals and people, nor does such an approach
require surgery or anesthesia.
The least invasive technique available to study EPR is the end organ approach.
These techniques include measuring heart rate, heart rate variability, blood pressure,
blood pressure variability, blood flow, and vascular resistance. Although this approach

2

has the lowest level of experimental control, it can be performed on animals and people
without the complications of invasive techniques and provides integrated information
about cardiovascular control.
Our lab has focused on using heart rate variability (HRV), an end-organ model, to
measure autonomic modulation during exercise. Using an exercise protocol developed
by Victor and Seals (1989) we found a dose dependent decrease in Mean R-R interval
to dynamic handgrip exercise at 20%MVC and 60%MVC.

However, MAP and low

frequency normalized units (LFnu: an index of sympathetic modulation) increased only
during 60%MVC handgrip exercise. These current data agreed with the results from
previous research using other methods to measure autonomic modulation (Victor and
Seals, 1989).
In addition to examination of the construct validity of this exercise protocol, we
have also established the stability of cardiovascular responses to rest and exercise over
a one-month period. Our data indicate that heart rate and indices of autonomic
modulation are stable with R-values exceeding 0.72 at rest and during exercise (Kluess,
Wood, Stone, Welsch, 2001). These values are consistent with previous reliability
studies using heart rate variability to measure autonomic modulation of cardiovascular
function (Amara and Wolfe, 1998; van de Borne, Montano, Zimmerman, Pagani,
Somers, 1997). Therefore we have demonstrated an ability to measure cardiovascular
responses to acute exercise.
The next step in this investigation was to test the specificity of the exercise
protocol to the EPR.

Post-exercise forearm occlusion is a commonly used test to

determine the contribution of the EPR to the exercise performed. The theory is that if
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EPR played a significant role in the muscle sympathetic and cardiovascular responses
to exercise, then occluding the blood flow to the muscle after cessation of the exercise
will result in a persistent elevation of muscle sympathetic activity and blood pressure
due to continued stimulation of group IV afferents by the metabolites trapped in the
muscle (Victor and Seals, 1989).
This effect has been demonstrated in both isometric and dynamic exercise using
afferent, efferent, and end-organ models (McClosky and Mitchell, 1972; Seals, 1989;
Victor and Seals, 1989; Hayward, Wesselmann, Rymer, 1991; Somers, Leo, Shields,
Clary, Mark, 1992). While post-exercise forearm occlusion is a commonly used and
accepted method to test for EPR activity during exercise, it is not without limitations.
Using efferent or end organ models it is not possible to completely control, eliminate, or
measure the influence of other cardiovascular control mechanisms that may also be
acting on the system. However, using post-exercise forearm occlusion does allow us to
make weak, but potentially important, inferences regarding the contribution of the EPR
to the cardiovascular response to exercise.
Thus, we added post-exercise forearm occlusion to our current handgrip exercise
model to evaluate the EPR specificity (Kluess, Wood, Stone, Wilson, Welsch, 2002).
One problem we discovered with our current model is it did not result in statistically
significant elevation of mean arterial pressure (MAP) above resting values in the control
condition.

While this is a common problem in small muscle mass activity it

nevertheless, suggests that we did not achieve an optimal stimulation of group IV
afferents during the exercise stimulus (dynamic handgrip exercise at 60%MVC)
(Somers et al., 1992).
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In contrast to our study, Victor and Seals (1989) found that dynamic handgrip
exercise at 60%MVC was a sufficient exercise intensity to induce persistent elevation of
sympathetic activity and blood pressure during post exercise forearm occlusion. One
reason for this discrepancy between our study and Victor and Seals (1989) is that they
used 2 minutes of exercise at 1 hz gripping frequency, while we used 5 minutes of
exercise at 0.5 hz gripping frequency. Although the total work in our study and Victor
and Seals (1989) were roughly matched, it appears that gripping cadence may play a
larger role in the magnitude of sympathetic activity produced during exercise than
previously understood.
In our original study, the participants had difficulty maintaining the 1 hz gripping
frequency for five minutes. Previous work by this lab has demonstrated that it takes 60
to 90 seconds of handgrip exercise at 60% MVC (1 hz) to obtain a stable (steady state)
heart rate (Kluess, Wood, Welsch, 2000). One of the assumptions of frequency domain
analysis is that the signal is stationary, thus, a five-minute data collection time during
exercise is critical to allow at least two minutes of data to be obtained in the steady state
period (Task force of the European Society of Cardiology and the North American
Society of Pacing and Electrophysiology, 1996). Therefore, we needed a change in the
protocol that would increase sympathetic activity during dynamic handgrip exercise at
60%MVC (0.5 hz), but not reduce the duration of the activity.
Reducing metabolite washout by reducing the blood flow through the working
muscle during exercise significantly increases the magnitude of sympathetic and
cardiovascular response to a given exercise mode and intensity through increased
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group III and IV afferents stimulation (Victor, Seals, Mark, 1987; Victor and Seals, 1989;
Sinoway, Hill, Pickar, Kaufman, 1993; Adreani and Kaufman, 1998).
Primary evidence for using reduced metabolite washout during exercise to
induce skeletal muscle afferents is a study by Adreani and Kaufman (1998) using a
decerebrate cat model. They demonstrated that group III and IV afferents were directly
stimulated with simulated walking activity with and without complete arterial occlusion.
However, the magnitude of change in group III and IV afferent firing frequency to activity
with arterial occlusion was 44% and 47% higher, respectively, than simulated walking
without arterial occlusion.
In humans exercise with reduced metabolite washout has also been used to
induce EPR activity. Mostoufi-Moab, Widmaier, Cornett, Gray, Sinoway (1998) used
cardiovascular response to dynamic handgrip exercise at 25%MVC with 50 mmHg of
pressure on the arm as a measure of EPR activity. A pressure of 50 mmHg on the arm
has been well established as a pressure sufficient to occlude venous outflow, but have
minimal influence on arterial inflow to the arm in humans (Cramer, Beach, Strandness,
1983).

Therefore, exercise with 50 mmHg on the arm would cause metabolites to

accumulate due to reduced venous outflow and stimulate the EPR.
Additionally, Victor et al. (1987) performed dynamic handgrip exercise at 30%
MVC with 50mmHg of pressure on the arm and found that it resulted in approximately 3
fold greater heart rate and blood pressure response, compared to exercise with no
pressure on the arm.

They specifically attributed the cardiovascular and muscle

sympathetic nerve activity responses to greater stimulation of the EPR through
increased trapping of metabolites during the activity.
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Therefore, reducing metabolite washout by applying 50 mmHg to the arm during
exercise is an established model to induce EPR activity using both afferent, efferent,
and end-organ models. In efferent and end-organ models, it is not possible to
completely attribute measures of autonomic modulation and cardiovascular response to
the EPR. However, when 50 mmHg of pressure is applied to the arm during exercise
and is followed by forearm occlusion weak inferences can be made concerning the
influence of the EPR during exercise.
Thus, we have modified our protocol to maximize skeletal muscle afferent
contribution by adding inflation of a blood pressure cuff to 50-mmHg to the high intensity
exercise. Occluding the arm during exercise has been shown to increase heart rate,
blood pressure, and muscle sympathetic activity from 10 to 24% and should be a
sufficient stimulus to optimally induce the EPR in the proposed study (Seals and Victor,
1991; Victor and Seals, 1989; Victor et al., 1987).
Subsequently, we wish to examine the effect of exercise training induced
adaptations to EPR. To date, two studies have shown significant changes in
cardiovascular responses to exercise with forearm occlusion and post-exercise forearm
occlusion (Somers et al., 1992; Sinoway, Shenberger, Leaman, Zelis, Gray, Baily,
Leuenberger, 1996; Mostoufi-Moab et al., 1998). However, all studies have used a
training stimulus below that which is known to induce an increase in sympathetic drive
from skeletal muscle afferents (less than 60%MVC)(Seals and Victor, 1991).
Additionally, the need to evaluate the training effect with an EPR specific test is
important.
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Mostoufi-Moab et al. (1998) and Somers et al. (1992) did use appropriate tests
for EPR, but Somers et al. (1992) was not able to induce a significantly elevated MAP
during post-exercise forearm occlusion either before or after training. This suggests
their exercise was not of a sufficient intensity to induce a large increase in sympathetic
activity, previously established to be necessary to maintain group IV afferent activity
during forearm occlusion (Victor and Seals, 1989).
Sinoway et al. (1996) did not test or train at an intensity believed to induce a
significant increase in sympathetic activity.

They concluded that the training

adaptations from their protocol were due to mechanoreceptor adaptations, not
metaboreceptor adaptations (Sinoway et al., 1996). Therefore, the ability of the EPR to
adapt to exercise training is still not well understood and there is a need for a training
and testing protocol specific to the EPR.
There is very little known concerning the chronic adaptations of the EPR.
However, there is significant evidence that a change in autonomic modulation does
occur with exercise training in as little as four weeks (Fisher and White, 1999; Schuit,
van Amelsvoort, Verheij, Rijneke, Maan, Swenne, Schouten, 1999; Levy, Cerqueira,
Harp, Johannessen, Abrass, Schwartz, Stratton, 1998; Seals and Chase, 1989; Somers
et al., 1992; Mostoufi-Moab et al., 1998; Sinoway et al., 1996). Additionally, non-neural
adaptations to exercise training such as vascular and skeletal muscle remodeling are
known to be significant after four weeks of training and may indirectly influence EPR
response to acute exercise and forearm occlusion (Sundberg, 1994 Mostoufi-Moab et
al., 1998, Sinoway et al., 1996; Booth and Thomason, 1991; Laughlin, Oltman, and
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Bowles, 1998). Therefore it is reasonable to assume that four weeks of training will be
a sufficient and appropriate training period to see changes in cardiovascular response
related to EPR activity.
Due to the non-specific nature of end-organ models to individual cardiovascular
control mechanisms, it will not be possible to exclusively attribute training-induced
changes in cardiovascular response to exercise and forearm occlusion to the EPR.
However, using single-arm forearm training does provide an advantage over large
muscle exercise in that the training effect is limited to the forearm and thus, changes in
plasma volume, blood flow shunting, and other whole body adaptations will have a
reduced effect on the cardiovascular changes observed (Fisher and White, 1999).
Before we can understand how to intervene in clinically significant changes in
EPR, we need to know if EPR is modifiable through training and/or pharmacology.
Improved understanding of the mechanism of change in autonomic modulation with
training and the adaptability of EPR will allow development of treatment strategies for
clinical populations effected by hyper- or hypo-active EPR.
Therefore, the purpose of this study was twofold: (1) to examine the
cardiovascular response to an acute bout of handgrip exercise inasmuch as it may be
reflective of stimulation of the EPR; and (2) to evaluate the influence of non-dominant
handgrip exercise training on cardiovascular response to exercise and post-exercise
forearm occlusion. We hypothesized that the modified exercise protocol would result in
persistent elevation of MAP and the index of sympathetic activity (LFnu) during postexercise forearm occlusion. Additionally, we hypothesized that exercise training will
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result in attenuated HRV and blood pressure responses to exercise and recovery in the
trained arm.
Previous studies have demonstrated that exercise training similar the current
study, resulted in approximately 20% increase in maximal hyperemic blood flow
following 5 minutes of forearm arterial occlusion (Alomari, Welsch, Prisby, Lee, Wood,
2001). Therefore, we hypothesized that blood flow would be higher in the trained arm
following forearm occlusion compared to the control arm. Consistent with other studies,
we also expected to see no significant changes in MVC and forearm circumference
(Alomari et al., 2001; Somers et al., 1992; Mostoufi-Moab et al., 1998; Sinoway et al.,
1996). Additionally, we expected no HRV, blood pressure, blood flow, MVC, or forearm
circumference changes in the no treatment group.
1.1 Clinical Relevance
The extent to which afferent information influences the autonomic response is
poorly understood, but appears to have important clinical relevance. Recent literature
suggests that dysfunction in skeletal muscle afferents may contribute to exercise
intolerance in the elderly and those with heart failure (Piepoli et al., 1999; Dinenno et al.,
1999). Before we can understand how to intervene in clinically significant changes in
EPR, we need to better understand EPR function during acute exercise in humans and
the plasticity of EPR to exercise training or pharmacology.

This may allow the

development of treatment strategies for clinical populations effected by hypo- or
hyperactive EPR.
Chronic changes in EPR sensitivity have been documented to occur as a result
of aging and chronic heart failure. These changes in EPR are associated with both
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decreased and increased EPR neural traffic and end organ response (Schuit et al,
1999; Dinenno et al., 1999; Zelis, Sinoway, Leuenberger, Clemson, Davis, 1991;
Sverrisdottir, Rundqvist, Johannsson, Elam, 2000). Investigations concerning the role of
EPR in exercise intolerance and cardiovascular response in aging and heart failure
need further development. Establishment of exercise protocols as well as improved
methods to study EPR contribution to autonomic modulation may aid in these studies.
Additionally, the investigation of EPR as a contributor to exercise intolerance in other
diseases such as peripheral vascular disease and diabetes should be advanced.
There is very little known concerning the chronic adaptations of the EPR.
However, there is significant evidence that a change in autonomic modulation does
occur with exercise training. Before we can understand how to intervene in clinically
significant changes in EPR, we need to know if EPR is modifiable through training
and/or pharmacology.

Improved understanding of the mechanism of change in

autonomic modulation with training and the adaptability of EPR will allow development
of treatment strategies for clinical populations effected by hyperactive EPR.
1.2 Limitations
1.

End-organ models provide only integrated information regarding cardiovascular

control mechanisms. Therefore, it is not possible to completely attribute any change in
cardiovascular response to exercise or forearm occlusion to the EPR.
2. Cardiovascular response to forearm occlusion may be confounded by factors such as
baroreceptor sensitivity, pain response unassociated with group III and IV afferents,
and/or changes in vascular function or control.
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3. The training effect for the EPR may occur later than four weeks, therefore, we may
see no change in cardiovascular response to exercise.
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CHAPTER 2 LITERATURE REVIEW
2.1 Introduction
Cardiovascular control during exercise involves a complex system of redundant
mechanisms that ensure adequate oxygen delivery to working muscles.

These

cardiovascular control mechanisms are both central and peripheral with each providing
unique information to the brain.
The cardiovascular control center integrates information from all of the peripheral
afferents and information from central command and the hypothalamus to create action
through the autonomic branch of the nervous system.

This branch of the nervous

system has two distinct parts called parasympathetic and sympathetic. The
parasympathetic branch of the autonomic nervous system originates in the nucleus vagi
in the medulla and innervates the heart through the vagus nerve. The sympathetic
branch of the autonomic nervous system originates in the cardiac accelerator nucleus of
the medulla. The sympathetic branch innervates both the heart and the vasculature.
During exercise, the autonomic nervous system responds to reduce blood flow to
non-working tissues and maximize blood flow to working tissues, while controlling blood
pressure. This occurs initially through a withdrawal of parasympathetic nervous activity
and an increase in sympathetic nervous activity, which result in increased heart rate,
stroke volume, and vascular resistance in the GI tract and non-working tissues
(Fagraeus and Linnarsson, 1976; Peterson, Armstrong, Laughlin, 1988; Rowell, 1997).
The signals to induce autonomic nervous stimulation to various parts of the body during
exercise are from central command, the hypothalamus, the respiratory stretch
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receptors, O2/CO2 receptors, the arterial and cardiopulmonary baroreceptors, and
skeletal muscle afferents.
Central command of cardiovascular control originates in the subthalamic
locomotor region of the brain and acts to induce parasympathetic withdrawal and
increase sympathetic activity by acting on the cardiovascular control center.

The

hypothalamus is active during exercise where there is an increase in body temperature.
Then the hypothlalmus acts to vasodilate the skin blood vessels (Brooks, Fahey, White,
1996).
In

the

respiratory

system

there

are

several

receptors

that

influence

cardiovascular control. The respiratory stretch receptors are located in the chest wall
and in muscles participating or assisting in respiration. When activated, their role is to
inhibit respiration. Additionally, the respiratory system has receptors that detect O2,
CO2, and pH.

These receptors decrease or increase breathing rate through the

medulla to optimize body levels of these elements (Brooks et al., 1996). In general, the
arterial baroreceptors detect changes in arterial pressure and induce changes in
autonomic nervous stimulation to maintain blood pressure within a narrow range. Since
blood pressure increases during exercise, the baroreceptors are believed to reset to a
new maintenance point. Therefore, during exercise the purpose of the baroreceptors is
to maintain sympathetic activity and to prevent arterial hypotension (Rowell, 1997). The
mechanism by which baroreceptor resetting occurs is not well understood, but may be
influenced by skeletal muscle afferents which originate in the nucleus tractus solitarii as
does the arterial baroreceptors reflex (Machado, Castania, Bonagamba, Salgado,
2000).
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2.1.1 Skeletal Muscle Afferents
Cardiovascular control during exercise is also influenced by receptors that detect
movement and metabolites in the muscle. Mechanoreceptors, such as golgi tendon
organs and muscle spindles, detect movement and stretch within the tendons and
muscle of active tissue.

These receptors have no direct link to the cardiovascular

control center, but do exert some influence through central command and possibly
through interneuron links in the spinal cord with other skeletal muscle afferents (Thomas
et al., 1998; Brooks et al., 1996; Appelberg, Hullinger, Johansson, Sojka, 1983;
Pedersen, Ljubisavljevic, Bergenheim, Johansson, 1998).
One of the most interesting and controversial mechanisms of cardiovascular
control originating in the skeletal muscle is the exercise pressor reflex (EPR).
According to Rowell (1997), the purpose of these skeletal muscle afferents and their
associated reflex is to "guard against hypoperfusion of the active muscle". This reflex
arc begins with receptors in the skeletal muscle and interstitial spaces, which detect
metabolites and movement in the working muscle. The information from the receptors
is transmitted to the cardiovascular control center of the brain through afferent neurons
called group III and group IV afferents.
sympathetic

nervous

stimulation

to

The action of this reflex is to increase

metabolically

active

muscular

movement.

Therefore, stimulation of the EPR results in increased heart rate, blood pressure, and
vascular resistance.
Unlike mechanoreceptors, the EPR does have a direct connection with the
cardiovascular control center of the brain. Evidence suggests that the ventrolateral
medulla is a critical region for expression of the EPR. Li, Hand, Potts, Wilson, Mitchell
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(1997), showed that the lateral reticular nucleus, the nucleus tractus solitarii, lateral
tegmental field, the vestibular nucleus, the subretrofacial nucleus, and the A1 region of
the medulla were activated with spinal stimulation to create static muscle contraction in
anesthetized cats.

Additionally, there is evidence that the area postrema in the

dorsomedial portion of the medulla is involved in modulating the nucleus tractus solitarii.
The nucleus tractus solitarii is also the primary baroreceptor reflex location, and
therefore may be the source of interaction between the baroreceptor reflex and the
EPR.

Additionally, Bonigut, Bonham, Stebbins (1997) found that area postrema

disruption resulted in enhanced blood pressure and heart rate response to static muscle
contractions in anesthetized cats, suggesting that the area postrema plays an important
role in baroreflex/EPR interaction. There is evidence that the baroreceptor reflex acts to
buffer the hypertensive effect of the EPR (Raven, Potts, Shi, 1997).
The spinal cord is another source of EPR modification by peripheral
mechanisms. The spinal cord portion of this reflex is a complex system of interneurons
that may be modified by intraspinal bradykinin and/or glutamate (Stebbins and Bonigut,
1996; Adreani, Hill, Kaufman, 1996). This is believed, although not well studied, to be
the source of mechanoreceptor/EPR interaction (Appelberg et al., 1983).
2.1.2 Morphology
Group III and IV afferents are a family of unencapsulated nerve endings
connected to afferent nerves. Group III afferent endings are located in the interstitial
space of the muscle, capillary walls, the venous vessel, the adventitia of lymph vessels,
in connective tissue of the peritoneum, and in the collagen fiber bundles of the tendon
(Andres, von During, Schmidt, 1985; MacLean, LaNoue, Gray, Sinoway, 1998). The
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afferent nerve of group III afferents are small (1-4micrometers), thinly myelinated nerve
fibers with conduction velocities of 2.6 to 30 meters/second (Rotto and Kaufman, 1988;
Thomas et al., 1998; Paintal, 1960).

Group IV afferents nerves are small (1-

4micrometers), unmyelinated nerves with conduction velocities less than 2.5
meters/second (Andres et al., 1985; Rotto and Kaufman, 1988). Group IV afferent
endings contain granulated vesicles and most likely release protein neurotransmitters
like substance P. They are located extensively in the blood vessels, lymphatic vessels,
and the interstitial space in the muscle (Andres et al., 1985; MacLean et al., 1998).
Although we know a great deal about the distribution and basic anatomy of GIII and GIV
afferents, the mechanism by which GIII and GIV afferents detect metabolites is, to date,
undiscovered.

However, there is evidence that GIII and GIV afferents respond to

metabolites such as lactate, adenosine, leukotrienes, prostaglandins, hydrogen ions,
and potassium ions released by the muscle (Thomas et al., 1998).
2.2 Models That Have Been Used to Evaluate EPR
Despite more than 70 years of study a great deal of controversy still exists
concerning the exercise pressor reflex (Mitchell et al, 1983). From this controversy a
number of hypotheses have arisen. One set of hypotheses is the central command
versus the exercise pressor reflex theory of cardiovascular control during exercise. The
Central command theory states that higher brain centers direct all cardiovascular control
and motor unit recruitment during exercise, while the exercise pressor reflex theory
states that peripheral mechanisms play an important role in cardiovascular control
(Mitchell et al., 1983).

To date, there is good evidence that central command in

combination with peripheral afferents influence cardiovascular control during exercise.
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However, the set of stimuli that influences the predominance of one mechanism of
cardiovascular control versus another is still under debate.

Within EPR literature, the

sets of hypotheses are called the traditional versus the emerging hypothesis of EPR
function.

The traditional hypothesis states that EPR only influences cardiovascular

control under conditions where there is a mismatch between blood flow and skeletal
muscle demand. The emerging hypothesis states that EPR is active and influencing
cardiovascular control both during low intensity exercise and under conditions where
blood flow and demand are not matched (Thomas et al., 1998).

Past and current

research has provided some insight into the validity of these hypotheses, but a great
may questions still need answering to further understand the mechanisms of
cardiovascular control during exercise.
There are a number of approaches that have been developed to identify the role
of EPR during exercise and test the exercise pressor reflex theory and the emerging
model of metabolite-sensitive afferents in acute exercise. The EPR can be broken
down into three distinct parts: the afferent arm of the reflex arc, the efferent arm of the
reflex arc, and the end organ response to neural modulation via EPR.
Models to evaluate the role of EPR during exercise also can be categorized
according to the part (described above) of the EPR from which they derive their
information. The afferent models are considered the most highly controlled approach to
evaluating the role of EPR during exercise, and directly measure afferent neural activity
at the nerve or in the spinal cord. Models employing this technique have been generally
performed on animals and tend to focus on central command versus EPR theory of
cardiovascular responses to exercise.
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Alternately, direct nerve recordings from the efferent arm of the reflex arc can
also be recorded and will be termed efferent models. Although experimental control
over central command is less complete in these models it is possible to perform efferent
measurement techniques in both animals and people, nor does such an approach
require surgery or anesthesia.
The least invasive technique available to study EPR is the end organ approach.
These techniques include measuring heart rate, heart rate variability, blood pressure,
blood pressure variability, blood flow, and vascular resistance. Although this approach
has the lowest level of experimental control, it can be performed on animals and people
without the complications of invasive techniques and provides integrated information
about EPR. While each of these models has limitations, all have provided unique and
valuable information regarding the role of EPR under various circumstances and the
conditions under which EPR functions.
2.2.1 Afferent Models
The most powerful model providing information regarding the role of EPR in
cardiovascular control during exercise is the decerebrate cat model. In this model, the
cerebrum of the cat is removed, thus eliminating central command by higher brain
centers but allowing breathing, heart rate, and neural transmission to continue without
the interference of anesthesia. Exercise activity is produced at the spinal cord through
stimulation of the ventral nerve roots.

This model has provided valuable evidence

supporting the existence of the EPR and highlighting some of the characteristics of
EPR.
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The first study using this model was McMahon and McWilliams (1992). Using
electrical stimulation of the sciatic nerve (10 and 50 hz pulse of 1 ms duration - contract
lasted 5 sec), McMahon and McWilliams (1992) found the latency of cardiac
acceleration following muscle contraction was 687 ms and suggesting that early
changes in R-R interval can be controlled from reflex activity in the working muscles.
Additionally, a further increase in reflex R-R interval response was eliminated by a bolus
of atropine indicating cardiac acceleration in response to muscular activity was due to
vagal withdrawal.
The characteristics of EPR were further explored by MacLean et al. (1998). They
used 3 and 5 hz twitch contractions of the sciatic nerve for 0.1 ms duration for 5
minutes. Additionally, they included micro dialysis probes in the muscle to measure
intramuscular concentrations of metabolites to evaluate the most likely metabolite that
stimulates EPR. They found a dose dependent heart rate response, but MAP only
increased at the highest stimulation rate.

Lactate, phosphate, hydrogen ions, and

potassium ions were all elevated during both stimulation frequencies, however,
following 10 minutes of recovery, lactate and hydrogen ion concentrations were still
elevated even though heart rate and blood pressure had returned to normal. Thus, they
concluded that EPR is also stimulated during lower intensity longer duration activity and
that potassium is the most likely metabolite stimulus for EPR activity.
Another study by Adreani, Hill, Kaufman. (1997) showed that simulated walking
activity in decerebrate cats directly stimulated the group III and IV afferents measured at
the spinal cord. A further study by Adreani and Kaufman (1998) demonstrated that
group III and IV afferents were also directly stimulated with simulated walking activity
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during arterial occlusion. However, the magnitude of group III and IV afferent response
to ischemic activity was 44% and 47% higher, respectively, than simulated walking
without arterial occlusion. Interestingly the hydrogen ion and lactate ion concentration
in the venous blood was not significantly different in the ischemic and non-ischemic
states, thus, suggesting that a metabolite other than H+ and lactate are responsible for
EPR during ischemia.
In summary, the decerebrate cat model has established that, in the absence of
higher brain centers, a reflex originating in the muscle increases heart rate and blood
pressure by initially stimulating vagal withdrawal.

This reflex operates at maximal

isometric workloads, very low intensity dynamic activities, and under conditions of
impaired blood flow which support the emerging model of EPR activity. The response
of this reflex appears to be dose dependent, but the metabolite that stimulates group III
and IV fibers is still under investigation.
Another method by which central control is reduced is the anesthetized animal
model. Although this model is less technically rigorous than the decerebrate cat model,
the presence of anesthesia during testing may alter autonomic function and nerve
impulses and thus, may change the behavior of the reflex or the actions resulting from
an active EPR. Despite the problems with this model, it has been used to provide
important information concerning the characteristics of EPR under conditions of reduced
input from central command.
Rotto and Kaufman (1988) used this model to investigate the metabolic byproduct stimulating EPR activity. They injected the femoral artery of anesthetized cats
with lactic acid, arachidonic acid, adenosine, and phosphate at rest. They found that
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infusion of lactic acid (400mM) resulted in increased the discharge rate of 69% of the
GIII and GIV afferents (latency time 5-10 sec) studied and caused an increase in arterial
pressure in 22 out of 30 trials.

Arachidonic acid (AA) injection resulted in a 50%

increase in discharge frequency (latency of 1-3 min) that lasted for 2-5 min after the
injection.

The addition of indomethacin attenuated the response to AA by 83%.

Interestingly, AA caused a decrease in arterial pressure of 10 to 76 mmHg in 33 out of
59 trials. Adenosine and phosphate caused 17% or fewer of the afferents studied to
increase their discharge frequency at rest.

Therefore Rotto and Kaufman (1988)

concluded that lactate and cyclooxygenase products are the most likely metabolites
responsible for EPR.
One of the more unique studies using this model was Sinoway et al., (1993).
They found that group III discharge frequency increased with the injection of La at rest
and decreased when dichloracetate (DCA), a drug that inhibits lactate dehydrogenase,
was added.

However, repeated exposure to lactate at rest reduced the discharge

frequency. This reduction in discharge frequency was reversed by muscle contraction.
Thus, suggesting that the metabolite receptors (group III afferents) have a relationship
with receptors of movement (group IV afferents).
In summary, this model has been primarily used to determine the metabolite(s)
responsible for stimulating the EPR under conditions of reduced influence from higher
brain centers. Although still controversial, the results of these studies suggest that the
most likely metabolites that stimulate EPR during isometric and dynamic exercise are
lactate and cyclooxygenase products. This conclusion is in conflict with the findings of
MacLean et al. (1998) who employed a decerebrate cat model and inter-muscular
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microdialysis.

While microdialysis metabolite collection is a superior method of

determining physiological levels of metabolites that may effect EPR, MacLean et al.,
(1998) based their elimination of lactate as an important EPR activating metabolite on
the evidence that HR and BP recovered from exercise before the lactate concentrations.
Although higher brain centers were eliminated in their experiment, they failed to
consider other autonomic reflexes that may play a predominant role during recovery
from exercise, such as the baroreceptor reflex. These findings do not conflict with the
findings of Adreani and Kaufman (1998) that suggested that lactate may not be the
predominant metabolite responsible for EPR activity during ischemia. Both of these
models suggest strongly that there is a continuum of group III and IV afferents that
respond to a variety of combinations of metabolites, muscular activity, and blood flow.
2.2.2 Efferent Models
Models like the decerebrate cat and anesthetized animal strongly support the
existence of the exercise pressor reflex and have demonstrated that when central
command is eliminated or reduced, this mechanism stimulates heart rate and blood
pressure to increase.

These models also strongly support the emerging model of

afferent contribution to cardiovascular control in that GIII and GIV afferents increased
discharge frequency to low intensity electrical stimulation as well as maximal tetanic
stimulation and ischemia. However, these models have provided no evidence that this
reflex plays a role during conscious activity and that the EPR occurs in humans to the
same degree as cats and rabbits.
Efferent models have become common to evaluate the role of EPR during
various

exercise

protocols

with

recent
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improvements

in

the

technique

of

microneurography. Microneurography involves inserting a tungsten electrode into a
nerve near the skin surface. The electrode is moved until a signal consistent with
sympathetic efferent activity is detected (Seals and Victor, 1991).

These data are

commonly expressed as either the number of sympathetic bursts per minute or as
sympathetic bursts per minute multiplied by the mean burst amplitude of the condition
and in termed muscle sympathetic nerve activity (MSNA).
The advantage of efferent models is that, although they are invasive, they do not
require anesthesia. Another advantage is that they measure peripheral sympathetic
neural output as a result of reflex activity. A disadvantage is these protocols cannot
eliminate the contribution of central command to the sympathetic output measured and
therefore cannot infer with a great deal of certainty that GIII and GIV afferent activity
caused the sympathetic response measured in these experiments. However, an indirect
approach for indicating GIII and GIV involvement used in efferent models is measuring
peripheral sympathetic output during post-exercise ischemia.

This procedure

theoretically prevents metabolites created during the previous exercise protocol from
leaving the area and thus, continues to act on the GIII and GIV receptors. Therefore,
the result of this manipulation is that sympathetic outflow and, subsequently, BP
remains elevated above rest, allowing the suggestion that the exercise responses were
due to EPR activity (Seals and Victor, 1991).
Despite the problems associated with efferent models, the experiments
performed have provided valuable information regarding human sympathetic responses
to various exercise protocols, active muscle masses, and magnitude of blood flow
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restriction. The most common exercise mode for use with microneurography recording
is isometric exercise of the forearm, typically lasting from 3 to 5 minutes.
Figure 2.1 summarizes the current literature regarding MSNA responses in
bursts per minute to isometric exercise at varying exercise intensities (symbol F). Each
point represents the peak mean change from resting MSNA (range: 15 to 38 bursts/min)
for each study. Isometric handgrip exercise results in a significant increase in the
sympathetic activity going to the forearm even at exercise intensities as low as 10% of
the participant's maximal voluntary contraction (MVC) in healthy adults (Saito, Iwatse,
Mano, 1986; Seals, 1989). This dose dependent effect was also seen with significant
mean changes in heart rate and blood pressure from rest. However, blood pressure did
not increase significantly until MSNA increased to 6 bursts per minute.
Dynamic exercise has a much different pattern of nervous and cardiovascular
response to exercise compared to isometric exercise. The results from a number of
studies using dynamic exercise intensities of 10% MVC to 60% MVC and a gripping
frequency of 0.7 to 1 hz are summarized in figure 2.1 (symbol ∇). Dynamic handgrip
activity does not result in a significant increase in MSNA until 60% MVC. However, the
change in heart rate and blood pressure from rest occurs with dynamic handgrip
exercise at 10%MVC (Victor et al., 1987; Victor and Seals, 1989; Saito et al., 1986).
When larger muscle groups are used, such as with arm cycling (symbol

in figure 2.1),

MSNA significantly increases from rest (25 burst/min difference) at 30% of MVC and is
accompanied by heart rate (32 beats/min difference) and blood pressure (25 mmHg
difference) changes (Victor et al., 1987; Victor and Seals, 1989).
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Figure 2.1: Summary of MSNA results in bursts per minute
for microneurography literature over different exercise protocols and
exercise intensities.
Therefore, the sympathetic response to isometric handgrip activity appears to
have a lower threshold for increasing sympathetic activity and cardiovascular response
than dynamic handgrip activity. However, the magnitude of cardiovascular response at
10 bursts/min above rest is greater with dynamic, than isometric handgrip exercise.
Additionally, an increase in sympathetic activity during dynamic activity in larger
muscle masses occurs at a lower relative workload than smaller muscle masses, but
induces a larger magnitude change in sympathetic and cardiovascular response. Seals
(1993), comparing isometric handgrip exercise at 30% MVC and isometric abduction of
the FDI muscle of the hand, further illustrated the muscle mass effect. They found that
both the magnitude of increase in sympathetic activity and cardiovascular response was
2 to 3-fold greater in the larger muscle mass compared to the smaller muscle mass.
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Reducing blood flow to the working muscle and following exercise also
significantly increases the magnitude of sympathetic and cardiovascular response to a
given exercise mode and intensity. Victor et al., (1987) performed dynamic handgrip
exercise at 30% MVC both with and without blood flow restriction. Exercise with blood
flow restriction resulted in approximately 3 fold greater heart rate and blood pressure
response, compared to exercise with no restriction.

Additionally, dynamic handgrip

exercise at 30%MVC with normal blood flow did not result in an increase in sympathetic
outflow, but when blood flow was restricted during exercise MSNA was 16 bursts/min
higher than rest. This magnitude of change in sympathetic activity is similar to the
magnitude of change seen with 35% of isometric activity (19 bursts/min above rest
(Seals, 1989).
Interestingly, the dose dependent effect described above does not occur with
larger muscle masses.

Arm cycling with no resistance and blood flow restriction

(250mmHg) resulted in a 2.7-fold greater heart rate, a 2-fold greater blood pressure
response, and a sympathetic increase of 25-bursts/min above rest (similar to arm
cycling at 30% normal blood flow).

However, arm cycling at 30% of the maximal

workload with restricted blood flow resulted in only a 1.3-fold increase in HR, 1.6-fold
increase in BP, and a 2.4-fold increase in MSNA, compared to the same exercise load
with no blood flow restriction (Victor and Seals, 1989).

This protocol was also

performed with 40 mmHg and 100 mmHg on the cuff during no load and 30% of the
maximal load arm cycling activity. These pressures did not result in a change in the
sympathetic or cardiovascular response to the activity.
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Post-exercise forearm occlusion is a commonly used test to determine the
contribution of the EPR to the exercise performed. The theory is that if EPR played a
significant role in the muscle sympathetic and cardiovascular responses to exercise,
then occluding the blood flow to the muscle after cessation of the exercise will result in a
persistent elevation of muscle sympathetic activity and blood pressure due to continued
stimulation of group IV afferents by the metabolites trapped in the muscle (Victor and
Seals, 1989).
Seals (1989) had their participants perform isometric handgrip exercise at
35%MVC and then post-exercise occlusion.

They found a persistent elevation of

muscle sympathetic activity and calf vascular resistance above resting values. This
effect did not occur when participants were allowed to recover without blood flow
restriction.

In agreement with these findings, Somers et al. (1992) found a 270%

increase in MSNA from rest during forearm occlusion following 33% isometric handgrip
exercise. However, heart rate and blood pressure were not significantly different from
rest. Following dynamic handgrip activity at 60%MVC, Victor and Seals (1989) found a
persistent elevation of MSNA and blood pressure, but not heart rate with post exercise
occlusion. However, post exercise occlusion had no effect on neural or cardiovascular
responses to dynamic handgrip exercise at 20%MVC.
Data from both dynamic handgrip and arm cycling suggest that restricting blood
flow lowers the threshold for increasing sympathetic activity and increases the
magnitude of the cardiovascular response for a given intensity of activity.

MSNA

appears to plateau in two arm cycling when blood flow is restricted regardless of the
resistance on the flywheel. These results from arm cycling activity suggest that there is
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an upper limit for increasing sympathetic activity in upper extremity activity.
Additionally, post exercise occlusion appears to maintain exercise-induced increases in
muscle sympathetic activity following both isometric and dynamic handgrip exercises.
However, when the exercise did not result in a significant increase in sympathetic
outflow, post exercise occlusion had no effect on neural or cardiovascular responses
during recovery.
2.2.3 End Organ Models
The terminal end of any reflex loop is the target or end organ. In the exercise
pressor reflex, the target organs are the heart and the vasculature. End organ models
for EPR include measurements of heart rate, blood pressure, heart rate variability, blood
pressure variability, blood flow, vascular resistance, and vascular conductance.
Measuring the response of these organs has provided important information regarding
autonomic control at rest and during exercise. End-organ models are the least specific
models to measure EPR influence over cardiovascular control, therefore, attributing the
end organ response exclusively to the EPR is difficult.
An advantage of these models is there are no mode, intensity, or muscle group
restrictions for exercise in animals and people. Additionally, end organ models are
generally non-invasive, therefore, making it less likely that measurement itself is altering
normal response and does not require anesthesia. An added advantage of end organ
models is both parasympathetic and sympathetic information can be inferred, allowing a
more complete view of autonomic control of the cardiovascular system during exercise.
Measurements of heart rate and blood pressure alone give us only very general
information regarding autonomic modulation at rest and during exercise.
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However,

analyzing heart period variation provides a unique measurement of autonomic
modulation of the cardiovascular system.
The theoretical framework for heart rate variability (HRV) as a measure of
autonomic modulation is based on the cardiac tissue processing of signals from the two
branches of the autonomic nervous system.

The parasympathetic branch of the

autonomic nervous system releases acetylcholine at the post ganglionic synapse which
acts directly on the SA node and atrial conduction fibers to open potassium channels
and hyperpolarize the cells.
acetylcholinesterase,

which

Acetylcholine is then rapidly broken down by

stops

the

hyperpolarization

stimulus.

Therefore,

parasympathetic neural activity has a very rapid tissue response to stimulation and a
rapid recovery from stimulation, thus exerting its hyperpolarizing influence at a high
frequency (0.15hz to 0.40 hz) (Task Force, 1996; Guyton and Hall, 2000).
In contrast, the postganglonic fibers of the sympathetic nervous system release
norepinephrine at the synapse, which stimulates beta-receptors to initiate the second
messenger cascade for cAMP.

This eventually results in opening of calcium and

sodium channels in the tissue and results in tissue excitability. Sodium and calcium
pumps removing the ions from the target cells cause recovery from sympathetic neural
activation.

Therefore, sympathetic neural activity has a very slow onset of tissue

response and a slow recovery from stimulation resulting in a low frequency of neural
activity (0.04 hz to 0.15 hz)(Task force, 1996; Guyton and Hall, 2000).
Predominant parasympathetic control of the heart results in high variation in the
R-R interval due to the rapid onset and recovery of the cardiac tissue to
parasympathetic nervous activity. Sympathetic stimulation of the heart results in a
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higher heart rate with less variability because of the prolonged tissue excitability
induced by sympathetic neural input. Through this hypothesis it is possible, in general,
to suggest that the standard deviation of the normal sinus R-R intervals (SDNN) indicate
a predominant parasympathetic or sympathetic modulation of the heart rate (Task force,
1996).
Evidence to support SDNN as a measure of autonomic modulation is that when
in animals or humans the Vagus nerve is cut, the SDNN decreases (Jokkel, Bonyhay,
Kollai, 1995; Task force, 1996). Additionally, during exercise, when parasympathetic
withdrawal and increase in sympathetic stimulation are known to occur, SDNN
decreases (Kluess et al., 2000; Iellamo, Pizzinelli, Massaro, Raimondi, Peruzzi,
Legramante, 1999).

Studies using paced breathing to induce an increase in

parasympathetic modulation of the heart have found an increased SDNN (Cooke, Cox,
Dietrich, Taylor, Beightol, Ames, et al., 1998; Lee, Aucoin, Wood, Welsch, 2000; Wood,
LeLeux, Welsch, Nelson, Kluess, Lee, 2001). SDNN also has predictive validity.
There have been a number of studies in adults and infants to suggest that lower
SDNN taken over a 24-hour period predict an increased risk for sudden death
(Lombardi, 2000). However, SDNN does not discriminate between the modulation by
branches of the autonomic nervous system and is influenced by the heart rate at which
the measurement was taken, thus reducing the value of comparison between people
and during exercise (Kluess et al., 2000).
Another measure of heart rate variability is the frequency domain.

This

technique is based on the previously mentioned frequency differences between the
branches of the ANS. Using frequency analysis, this technique attempts to discriminate
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between R-R intervals occurring in a frequency band of parasympathetic neural
stimulation of the heart (high frequency: 0.15 hz to 0.40 hz) and in a frequency band of
sympathetic neural stimulation of the heart (low frequency: 0.04 hz to 0.15 hz) (Task
force, 1996).
The validity of assigning various frequencies to parasympathetic and sympathetic
modulation is based on a number of studies.

Frequency distributions of the R-R

intervals from people with heart transplants and animals after undergoing surgical
vagotomy and sympathectomy have shown no power in the frequency bands assigned
to ANS neural input (Task force, 1996). In neurally intact animals and humans, beta
blockade resulted in a reduction in the low frequency power.
Using the parasympathetic blocker atropine reduced the power of the high
frequency domain, but also decreased the power in the low frequency domain
somewhat (Task force, 1996).

Exercise causes a reduction in the high frequency

power, and an increase in the low frequency power, but also causes a reduction in the
total power of the frequency spectrum (Iellamo et al., 1999; Gonzalez-Camarena,
Carrasco-Sosa, Roman-Ramos, Gaitan-Gonzalez, Medina-Banuelos, Azpiroz-Leehan,
2000).
2.2.3.1 HRV as a Measurement of Autonomic Modulation
Few studies to date have used to HRV as a measurement of exercise induced
change autonomic modulation. Fagraeus and Linnarsson (1976) reported that initial
changes in heart rate during exercise were primarily due to parasympathetic withdrawal.
Additionally Hollander and Bouman (1975) demonstrated, using pharmacological
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blockade, that the decrease in R-R interval during low intensity exercise was mediated
by vagus nerve activity without an increase in sympathetic drive.
More recent work by Kurita, Takase, Hikita, Uehata, Nishioka, Nagayoshi, et al.
(1999) found that heart rate, blood pressure, and high frequency power increased in
response to isometric handgrip exercise, but low frequency power and cardiac
norepinephrine did not change from rest to exercise. Iellamo, et al. (1999) used 4
minutes of static leg extension at 30%MVC followed by 5 minutes of post exercise leg
occlusion.

They found normalized low frequency power increased with static leg

exercise and remained high during post exercise occlusion. High frequency normalized
power decreased during exercise, but returned to baseline levels during post exercise
occlusion. They concluded that EPR was active during exercise and post exercise
occlusion. Heart rate was predominantly controlled by the baroreceptor reflex during
post exercise occlusion, but blood pressure remained elevated due to EPR.
Gonzalez-Camarena et al. (2000) compared the HRV response of isometric
(30%MVC) and dynamic (30 to 60%VO2max, 60 rpm, 6 min) quadriceps femoris
exercise. Isometric exercise resulted in higher SDNN and heart rate compared to rest
and both dynamic exercise intensities. Low frequency and high frequency power was
significantly higher during isometric exercise compared to rest and both dynamic
exercise intensities.

The HF normalized units were higher with isometric exercise,

compared to both dynamic exercise intensities. They concluded that the cardiovascular
responses to isometric and dynamic exercise are not controlled through the same
mechanisms and speculated that the baroreceptor reflex may play a more dominant role
in isometric compared to dynamic exercise.
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Additionally, our lab has established the validity and reliability of using HRV as a
measure of autonomic modulation during dynamic handgrip activity (Kluess et al., 2000;
Kluess et al. 2001). We found a dose dependent response of heart rate, frequency
domain indices of autonomic modulation and blood pressure during low (20%MVC) and
high (60%MVC) intensity dynamic handgrip exercise. SDNN did decrease with exercise,
but was not dose dependent. These data agreed with the results from Victor and Seals
(1989) using MSNA as a measure of sympathetic modulation.

Thus, we were

successful in observing changes in autonomic nervous system modulation and that
autonomic change was accompanied by dose dependent changes in heart rate and
blood pressure.
In addition to testing the constructive validity of this protocol, we have also
established the stability of cardiovascular responses to rest and exercise over a onemonth period. Our data indicated that heart rate and indices of autonomic modulation
are stable with R-values exceeding 0.72 at rest and during exercise (Kluess et al.,
2001). These values are consistent with previous reliability studies using heart rate
variability to measure autonomic modulation of cardiovascular function.
Therefore, HRV can be used to assess autonomic modulation of the heart during
rest and exercise with results that agree with efferent models. Iellamo, et al. (1999)
demonstrated that HRV can be used to assess autonomic modulation during post
exercise occlusion, and therefore, may be a suitable non-invasive tool to better
understand the role of the EPR during exercise.
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2.2.4 Blocking the EPR
One of the problems with both efferent and end-organ models are the lack of
specificity to a particular mechanism of cardiovascular control.

One method to

overcome this problem is using a chemical that block the mechanism of cardiovascular
control you wish to study.

A disadvantage of using a blocker is, by altering the

response of one of the mechanisms of cardiovascular control, it may alter the behavior
of other mechanisms. Despite this disadvantage, blockers have been used to assess
the role of EPR in cardiovascular control during exercise.
Blockers that have been used in EPR research focus on reducing the amount of
metabolite production during exercise. Therefore, cyclooxygenase inhibitors, such as
aspirin, ketoprofen, and indomethicin, which block prostaglandin production, have been
successful in reducing the cardiovascular responses to exercise.

Additionally,

dichloracetate and glycogen depletion, which reduces lactate production also, reduces
EPR response.
Rotto et al. (1990) found that Aspirin and indomethacin attenuated group IV
afferent discharge by ~82% during a two stimulated muscle contractions in anesthetized
cats.

Darques, Decherchi, and Jammes (1998) using aspirin and dicloracetate in

paralyzed and anesthetized rabbits during exercise supported these findings. They
found a 44 to 75% decreased group III and IV afferent activity with the blockers during
muscle stimulation with no change in resting afferent activity.
The effect of ketoprofen (1 mg/kg of body weight) in humans during static
handgrip activity has also been studied. Fontana et al. (1994) found a 55% decrease in
respiratory frequency, 22% decrease in mean arterial pressure, and an 11% decrease
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in heart rate.

EPR in humans also appears to be lactate sensitive. Sinoway,

Wroblewski, Prophet, Ettinger, Gray, Whisler, et al. (1992) found a 12% decrease in
blood pressure (BP) during post-leg exercise occlusion following glycogen depletion to
reduce lactate production.
Our lab has also attempted to develop a blockade model for EPR. We used
Aspirin (ASA) at doses of 80 mg, 325 mg, and 650 mg during low intensity dynamic
handgrip exercise (20%MVC), high intensity dynamic handgrip exercise (60%MVC),
forearm occlusion following 60%MVC exercise, and rest. We found lower indices of
sympathetic activity during post exercise forearm occlusion with 80 mg ASA; higher
systolic blood pressure during post exercise forearm occlusion with 325 mg ASA; but
higher spontaneous breathing R-R interval with 650 mg ASA compared to the control
visit (Kluess et al., 2002).
Our conclusions were that reduction in sympathetic activity during forearm
occlusion with 80-mg of ASA was most likely a result of attenuated group IV afferent
firing. Additionally, ingestion of 325-mg of ASA resulted in increased systolic blood
pressure during forearm occlusion and is consistent with changes in vascular
compliance. This effect was reversed with 650-mg of ASA and resulted in lower resting
heart rate most likely a result of a change in intrinsic heart rate, rather than a change in
autonomic modulation.

These findings suggest that aspirin influences cardiovascular

control even during small muscle activity and suggest that aspirin in doses of 325-mg or
more has a broad spectrum influence on the body (Kluess et al., 2002).
Therefore, chemicals that block the production of prostaglandins, leukotrienes,
and lactate result in reduced group III and IV afferent firing in cats and rabbits. In
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humans, cardiorespiratory response to arm and leg activity is significantly reduced when
chemicals that block the cyclooxygenase pathway or lactate production are used.
2.3 Chronic Changes in EPR Activity
While there is good evidence that the EPR exists, and responds to metabolic and
movement stimuli, there is little evidence concerning EPR adaptations to exercise
training. However, there is evidence that autonomic nervous system modulation
changes as a result of exercise training in younger people and good evidence that
exercise training alters autonomic modulation in older people, people with heart
disease, and people with renal disease, but the mechanism of these changes are poorly
understood (Levy et al., 1998; de Meersman, 1993; Ng, Callister, Johnson, Seals, 1994;
Braith, Welsch, Feigenbaum, Kluess, Pepine, 1999; Deligiannis, Kouidi, Tourkantonis,
1999; Duru, Candinas, Dziekan, Goebbels, Myers, Dubach, 2000; Stein, Ehsani,
Domitrovich, Kleiger, Rottman, 1999; Hull, Vanoli, Adamson, Verrier, Foreman,
Schwartz, 1994).
2.3.1 Forearm Exercise Training
Forearm exercise training is the most common mode for attempting to separate
out various mechanisms of cardiovascular control because it allows some separation
between changes in central command and peripheral mechanisms of cardiovascular
control (Fisher and White, 1999). Additionally, with forearm training, the training effect
is limited to the forearm and thus, changes in plasma volume, blood flow shunting, and
other whole body adaptations have a reduced effect on the cardiovascular changes
observed.
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Somers et al. (1992) had 8 men perform 6 weeks of dominant arm training at
30%MVC.

They found no difference in heart rate or MAP response to isometric

handgrip exercise at 33%MVC, but MSNA response was significantly lower during
exercise and post exercise forearm occlusion following training. Mostoufi-Moab et al.
(1998) trained the non- dominant arm in 10 men, 5 days per week for 4 weeks at
30%MVC.

They found that training had no effect on cardiovascular and metabolic

response to rhythmic handgrip activity at 25%MVC. However, when this exercise was
performed with 50 mmHg of pressure on the arm, the trained arm MAP ()12 mmHg),
lactate, and pH response to activity was decreased. They concluded that the EPR was
modified as a result of training.
Sinoway et al. (1996) used the same training protocol as Mostoufi-Moab et al.
(1998) and found an increased MSNA and forearm resistance and a decreased change
from rest in lactate, MAP, arterial norepinephrine, and forearm blood flow during
rhythmic handgrip exercise at 25%MVC. Since they saw these changes at an exercise
intensity that was below that which is believed to activate group IV afferents, they
concluded that this training changes mechanoreceptors (group III afferents), but not the
metaboreceptors (group IV afferents).
One of the potential reasons that there are mixed results regarding forearm
training and EPR is the intensity of the training itself. All three studies mentioned above
used a training intensity below that which is believed to induce an increase in
sympathetic activity caused by EPR (Seals and Victor, 1991). Additionally, the need to
evaluate the training effect with an EPR specific test is important. Mostoufi-Moab et al.
(1998) and Somers et al. (1992) did use appropriate tests for EPR, but Somers et al.
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(1992) was not able to induce a significantly elevated MAP during post-exercise forearm
occlusion either before or after training. This suggests their exercise was not of a
sufficient intensity to induce a large increase in sympathetic activity, previously
established to be necessary to maintain group IV afferent activity during forearm
occlusion (Victor and Seals, 1989).
Sinoway et al. (1996) did not test or train at an intensity believed to induce a
significant increase in sympathetic activity. They did see blood pressure and blood flow
changes at 25%MVC which has not been previously shown. However, Sinoway, et al.
(1996) used an intra-arterial pressure gauge to measure BP. The higher sensitivity of
this instrument as compared to auscultory BP measurements explains this result.
2.3.2 Autonomic Modulation Following Exercise Training
While forearm exercise training is the most specific method for identifying
mechanisms of cardiovascular control changes with exercise training, there is little
evidence to support EPR-specific changes in autonomic modulation. However, there is
good evidence that large muscle exercise does result in a change in autonomic
modulation, both at rest and during exercise.
Fisher and White (1999) used dynamic heel raise exercise training for 6 weeks
and found a 28% reduction in diastolic blood pressure and heart rate to isometric
exercise at 30% MVC, with no change in cardiovascular response to post exercise leg
occlusion compared to pre-training. However, they also observed a 24% decrease in
diastolic pressure and heart rate in the untrained limb. They concluded that the training
resulted in adaptations to central command.
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Schuit et al. (1999) had healthy people between the ages of 60 and 80 years
aerobically train for 6 months.

They found a 6 to 15% increase in 24-hour HRV

parameters following training. Additionally, Stein et al. (1999) found a 13% increase in
SDNN and a 30% increase in VO2max following 9 months of moderate intensity
exercise training in people in their 60's.
Short term HRV (collection time of 5 minutes or less) has not been used
frequently for evaluating the training effect.

Levy et al. (1998) aerobically trained

younger (range: 24-32 years) and older men (range: 60-82 years) for 6 months. HRV
was collected in two-minute intervals at rest and during each stage of a cycle ergometer
graded exercise test.

They found a higher standard deviation of the normal R-R

intervals (SDNN) in both groups and no significant difference between the groups
following training.

The decrease in SDNN from baseline to 400 kpm was greater

following training in both groups.
Additionally, Seals and Chase (1989) reported a decreased forearm vascular
resistance during lower body negative pressure following 30 weeks of vigorous aerobic
training in middle aged men. They concluded that the training resulted in a higher
maximal exercise capacity, but did not change baroreceptor reflex control of the heart.
The mechanism of attenuated forearm vascular resistance following training is not
known
2.3.3 Non-Neural Training Adaptations that Affect EPR
It is possible that the EPR itself does not change with training, but exercise
training results in non-neural adaptations that reduce the stimulus that induces EPR
activity.

This may include skeletal muscle changes that reduce the amount of
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metabolites produced during exercise, blood flow changes to the working muscle, or
non-neural cardiovascular changes.
Skeletal muscle metabolic, morphologic, and histological changes may influence
EPR stimulation during exercise. It is well known that exercise training results in an
increase in mitichondrial volume, decreased blood lactate, and improved motor unit
recruitment (Brooks et al., 1996). The magnitude of change from baseline in a given
physiological variable is directly related to the intensity and amount of time the exercise
is performed (Spina, 1999). The time course of these changes depends largely on the
variable measured, but is generally accepted to take 7 to 14 days to see a significant
change in muscle proteins and blood lactate (for a comprehensive review see Booth
and Thomason, 1991).
Additionally, there is evidence that restricting blood flow to the muscle being
trained can amplify the training effect. Using 4 weeks of leg exercise training with 50
mmHg of pressure on the leg, Sundberg, 1994 found a 20% higher in VO2peak, ~20%
higher citrate synthetase concentration, 30% higher capillary to fiber ratio, and 10%
higher glycogen concentration in the leg trained with low blood flow compared to no
training.

Previous work in afferent and efferent models have demonstrated that

reducing blood flow to the working muscle is the most powerful stimulus for EPR activity
and thus, should induce the largest magnitude change in EPR response to chronic
activity.
Improvements in blood flow with exercise training may also influence the activity
of the EPR. Vascular remodeling as a result of exercise training occurs at a very rapid
rate. Several studies have shown that 4 weeks of training results in increased vessels
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diameter in humans. Additionally, changes in NO production and vascular reactivity
change in as little as 4 days (Laughlin, Oltman, Bowles, 1998).
Other non-neural cardiovascular adaptations to exercise may also influence the
EPR response. Five months of long duration cycling training in young healthy men
resulted in a decreased resting heart rate and increased VO2max, left ventricle
diameter, septal thickness, and left ventricular volume in diastole.

These occurred

without a significant change in heart rate variability (time and frequency domain)
(Bonaduce, Petretta, Cvallaro, Apicella, Iannicieloo, Romano, et al., 1998).

These

findings indicate that a change in intrinsic rate occurred rather than an alteration in
autonomic modulation.
There is limited evidence with forearm exercise to suggest that the EPR
response to activity may change with exercise training.

However, there is good

evidence that the autonomic nervous system response to rest and activity alters
following a period of exercise training.

The contribution of the EPR to autonomic

nervous system response both before and after training remains to be elucidated.
Additionally, the mechanism by which EPR alters with training is not well
understood.

Currently methodology has not been able to distinguish whether the

change in EPR activity is due to alterations in the stimulus (metabolic or blood flow
changes) or is an adaptation of the reflex itself (reduced receptor sensitivity). Better
understanding of both the contribution of EPR to autonomic modulation during exercise
and the mechanism by which the EPR response is modified will provide us with a better
understanding of cardiovascular control.
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2.4 Current Clinical Problems
Chronic changes in EPR sensitivity have also been documented to occur as a
result of aging and chronic heart failure. These changes in EPR are associated with
both decreased and increased EPR neural traffic and end organ response. Although
little information exists concerning EPR response in older individuals, there is consistent
evidence of decreased HRV and higher efferent sympathetic nerve activity at rest and
during exercise (Schuit et al, 1999; Dinenno et al., 1999).
Additionally, there is evidence that blood flow is lower and heart rate response to
the onset of exercise is slower, and oxygen consumption is reduced compared to
younger individuals (Brooks et al., 1996; Dinenno et al., 1999). Another factor that may
add to changes in EPR sensitivity is a loss of muscle mass and an increase in the
percentage of slow twitch fibers in aging muscle (Brooks et al., 1996). Wilson, Dyke,
Parsons, Wall, Pawelczyk, Williams, Mitchell. (1995) have shown that active fast twitch
muscle has a higher EPR response than slow twitch muscle in rabbits. Therefore, it is
possible that changes in EPR response may contribute to autonomic modulation
changes seen in older individuals.
Considerably more literature exists linking EPR dysfunction with exercise
intolerance in people with chronic heart failure. In addition to very high sympathetic
nervous activity in people with heart failure both at rest and during exercise, peripheral
adaptations to chronic heart failure may contribute to abnormal EPR activity (Zelis et al.,
1991; Sverrisdottir et al., 2000).
One of the modifications of the skeletal muscle to heart failure is a reduction in
the number of slow twitch and an increase in the number of fast twitch fibers.
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Concomitantly, there is an overall reduction in the capacity for oxidative metabolism in
skeletal muscles of the whole body. These changes result in greater lactate, potassium,
and hydrogen ions all, which have a potent excitatory effect on GIII and GIV afferents in
humans and animals (Zelis et al., 1991). Impaired blood flow to the working muscle as
a result of impaired blood shunting, vascular dysfunction, and poor venous outflow may
also contribute to an elevated EPR response to activity (Zelis et al., 1991).
Notarius, Atchison, Floras (2001) found a lower threshold and higher maximal
activation for increase in MSNA with heart failure compared to controls during isometric
and moderate intensity non-ischemic exercise. Piepoli et al. (1999) also found evidence
of hyperactive EPR in patients with heart failure.

In this study, all heart failure and

control participants had an increase in systolic and diastolic blood pressure with post
exercise occlusion, but magnitude of change was greater in people with more severe
heart failure.

Additionally, they found significant correlations among ventilatory

response to post exercise occlusion, peak VO2, and exercise intolerance.

They

concluded that EPR is hyperactive in patients with heart failure and may contribute to
feeling of breathlessness and exercise intolerance.
Although the chronic adaptations to heart failure would suggest that EPR activity
is elevated during exercise, there is some evidence that EPR is hypoactive in patients
with heart failure. In agreement with studies named above, Negrao, Rondon, Tinucci,
Alves, Roveda, Braga, et al. (2001) observed that MSNA at rest was related to disease
severity. However, they also noted that MSNA and forearm vascular resistance change
with mild and moderate isometric handgrip exercise was not different among groups
(controls, mild heart failure, and severe heart failure). Sterns, Ettinger, Gray, Whisler,
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Mosher, Smith, et al. (1991) found that MSNA remained high in controls during post
exercise occlusion, but declined in patients with heart failure. Additionally, Negrao et al.,
(2001) observed that post exercise occlusion resulted in persistent elevation in MSNA
and MAP in people with mild heart failure and controls, but in people with severe heart
failure, MSNA and MAP returned to control values.
Therefore, considerable evidence exists to suggest that resting sympathetic
activity to the periphery is high in people with heart failure and the magnitude of
sympathetic activity is related to disease severity. However, some controversy exists
concerning changes in sympathetic activity during exercise in people with heart failure.
There is little disagreement that sympathetic activity is higher during exercise in heart
failure compared to controls, but some studies have shown that the change from rest to
exercise is not different from control participants. Information for post exercise forearm
occlusion is also mixed and suggests that people with mild heart failure may have little
to no hyperactivity in EPR response, but with more severe disease EPR may actually be
hypoactive.
Investigations concerning the role of EPR in exercise intolerance and
cardiovascular response in aging and heart failure needs further development.
Establishment of exercise protocols as well as improved methods to study EPR
contribution to autonomic modulation may aid in these studies.

Additionally, the

investigation of EPR as a contributor to exercise intolerance in other diseases such as
peripheral vascular disease and diabetes should be advanced.
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2.5 Conclusions and Future Directions
EPR appears to operate under a complex system of sensitivity to metabolites
and muscular movement, which needs to be taken into account when studying
cardiovascular control. Evidence suggests that multiple metabolites may be involved
and related to the mode of exercise and the blood flow/metabolism mismatch involved.
Further study concerning the conditions under which each metabolite(s) is most
effective in stimulating EPR is vital to allow development of methodology to better
isolate the EPR from other mechanisms of cardiovascular control. Additionally, better
understanding of the receptor and neural pathways associated with EPR would allow
development of pharmacological tools to intervene when EPR is hyper- or hypo-active.
EPR research is based on two basic sets of hypotheses. One of these sets of
hypotheses is the central command versus the exercise pressor reflex hypotheses of
cardiovascular control during exercise. The central command theory states that higher
brain centers direct all cardiovascular control and motor unit recruitment during
exercise, while the exercise pressor reflex theory states that peripheral mechanisms
play an important role in cardiovascular control (Mitchell et al., 1983). Current
knowledge about the EPR and other mechanisms of cardiovascular control cast
significant doubt on the strict interpretation of the central command theory, however, the
complex system of central command and peripheral cardiovascular control mechanisms
is poorly understood.
Observations in afferent models suggest that parasympathetic withdrawal is
mediated by EPR. However, evidence presented in efferent and end-organ models
suggests that dynamic exercise has a higher degree of central command influence
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compared to isometric exercise (Gonzales-Camerena et al., 2000; Illeamo et al., 1999;
Seals and Victor, 1991). This conflict among models concerning the central command
and exercise pressor reflex theories may be explained by the suggestion that EPR has
a weak parasympathetic control aspect, which is usually overwhelmed by the more
powerful central command. However, in afferent models (decerebrate cat/anesthetized
animals) central command is eliminated or reduced which may allow this aspect of EPR
to be expressed.
The other set of hypotheses influencing EPR literature is the traditional versus
the emerging hypothesis of EPR function. The traditional hypothesis states that EPR
only influences cardiovascular control under conditions where there is a mismatch
between blood flow and skeletal muscle demand. The emerging hypothesis states that
EPR is active and influencing cardiovascular control both during low intensity exercise
and under conditions where blood flow and demand are not matched (Thomas et al.,
1998). Data from isometric handgrip, dynamic handgrip, arm cycling and isometric leg
extension suggest that restricting blood flow to the working muscle lowers the threshold
for increasing sympathetic activity and increases the magnitude of the cardiovascular
response for a given intensity of activity and supports the traditional hypothesis (Saito et
al., 1986; Victor et al., 1987; Seals, 1989; Victor and Seals, 1989).
Afferent models (decerebrate cat) support the emerging hypothesis that low
intensity dynamic exercise also induces EPR activity.

However, in humans the

threshold for inducing EPR activity appears to be higher.

Efferent and end-organ

models suggest that EPR is most active under conditions where blood flow is restricted
for a period of time (occlusion or isometric exercise), but is active under conditions of
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high intensity (60%MVC or greater) resisted exercise in the forearm and low intensity
resisted exercise in the leg and upper body (30%MVC or higher).

Therefore, in an

intact subject, the traditional hypothesis of EPR activity is partially supported in that the
relative contribution of EPR is related to the degree of blood flow restriction in the
working muscle. However, EPR activity is also related to the size of the muscle mass
used, and the amount of resistance to movement supplied by the activity, which
somewhat supports the emerging hypothesis.
Therefore, different models for evaluating EPR support the basic theoretical
framework of the current hypotheses.

Future research should focus on developing

models of EPR function that are non-invasive and involve minimal interference with
other cardiovascular control mechanisms. Additionally there is a need to move EPR
research to more functionally significant models such as, lower limb exercise.
There is very little known concerning the chronic adaptations of the EPR.
However, there is significant evidence that a change in autonomic modulation does
occur with exercise training. Before we can understand how to intervene in clinically
significant changes in EPR, we need to know if EPR is modifiable through training
and/or pharmacology.

Improved understanding of the mechanism of change in

autonomic modulation with training and the adaptability of EPR will allow development
of treatment strategies for clinical populations effected by hyperactive EPR.
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CHAPTER 3 MATERIALS AND METHODS
3.1 Participants
Volunteers (age 18 to 30 years of age) were asked to participate in this study.
The sample size estimate for this study was based on a desired type I error rate of 5%
and type II error rate of 20% and for a longitudinal study with a control group.

The

calculation for the estimate made use of the effect size (ES), which was calculated as
the smallest difference worth detecting divided by the expected standard deviation of
the parameter of interest. The calculation also made use of the test-retest reliability of
the parameter (r).
The primary variable of interest was the natural logarithm of normalized units for
low frequency power (LFnu). Therefore, we estimated the sample size based on the
expected behavior of this parameter. While the effect of exercise training on a reactivity
measure, in general, has been documented in our laboratory, the magnitude of change
in this variable following dynamic handgrip exercise was not known. Therefore, we also
estimated the sample size based on the expected values for reactive hyperemic blood
flow (RHBF). Our laboratory has previously documented training adaptations in RHBF
following handgrip exercise training.

We used the most conservative of the two

estimates for the determination of the sample size for the study.
Estimating sample size using LFnu (Lee, 2001; Kluess et al., 2001):
ES = smallest difference to detect / standard deviation = 0.3units / 0.5 units = 0.6
N = 32 / ES2 = 32 / 0.62 = 89
n(total) = 2N(1-r)
r for LFnu = 0.87
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n = 178 (0.13) = 23.1 = 12 per group
Estimating sample size using reactive hyperemic blood flow (RHBF)(Alomari et al,
2001):
Effect size = smallest difference to detect / standard deviation = 5units / 8 units = 0.63
N = 32 / ES2 = 32 / .632 = 80
n(total) = 2N(1-r)
r for RHBF = 0.93
n = 160 (0.07) = 11.2 = 6 per group
All volunteers were healthy adults without any overt signs such as diabetes, heart
disease, hypertension, emphysema, gastrointestinal disturbances or bleeding or
gynecological problems. Individuals with any current medical problems (including those
listed above), current infection, or on medication known to affect cardiovascular function
were excluded from the study (see appendix B for the medical history questionnaire).
Additionally, volunteers that had taken aspirin within two weeks prior to testing were
excluded.
3.2 Design
This study involved an experimental design and made use of a mixed-model
ANOVA to test for main effects of treatment and test condition as well as treatment by
condition interaction. There were two levels of treatment (trained arm vs. control) and
two levels of conditions (pre versus post). Additionally, the effect of the treatment was
tested against two controls (internal control, i.e. dominant arm, and an external control,
i.e., untrained non-dominant arms of age and gender matched participants). Thus the
study made use of two mixed-model ANOVAS, one including an internal control, and
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one including an external control.

A more complete description of the statistical

comparisons is given in tables 3.1 to 3.6.
3.3 Procedures
Participants reported to the laboratory on two occasions for testing. All visits
were held prior to 11AM and participants were asked to refrain from eating, drinking,
and exercising at least 12 hours prior to the test.
3.3.1 Session 1
Upon arriving at the laboratory, participants were asked some general questions
about their health history in order to assess for the presence of any disease, condition,
or medical therapy that might affect cardiovascular function.
The circumference of both forearms was measured using a measuring tape at
quarter distances from the midolecranon process to the ulnar styloid (sites 1-4,
respectively). While lying in a supine position, the participant was asked to squeeze the
handgrip dynamometer attachment (Biodex Medical Systems, Shirley, New York) as
hard as they could for 5-seconds. They were allowed three trials with 30 seconds in
between each trial. The three MVC's were averaged and multiplied by 0.60 to derive
the torque used during the exercise condition (60% MVC). The participant was then
instrumented with equipment to record blood flow, respiratory rate, ECG, and blood
pressure (see diagram C.1 in appendix C for a diagram of instrumentation for testing the
right arm).
An EC-5R plethysmography system (Hokanson, 1995) with a mercury-in-silastic
strain gauge and blood pressure cuffs on the arm and wrist were used to obtain forearm
blood flow measurements. Blood pressure cuffs were positioned around the participant's
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arm and wrist on the side to be exercised, and a mercury-in-silastic strain gauge placed
around the forearm approximately 10 cm distal to the olecranon process for
measurement of resting and post-occlusion blood flow. The forearm was extended,
slightly supinated, and supported by a Styrofoam block. Baseline blood flows were
recorded at a paper speed of 5 centimeters/second and reactive hyperemia blood flow
(RHBF) was recorded at a paper speed of 25 centimeters/second.

Additionally, a

pneumotachometer was secured around the participant's torso and interfaced with the
Biopac MP100 to measure respiratory frequency during the protocol.
Heart rhythm was continuously collected using a 3-lead ECG interfaced with a
Biopac MP100 and its companion software Acqknowledge (model MP100A, Biopac Inc.,
Santa Barbara, CA). All data was collected at 200hz. Lastly, the non-working arm was
fitted with a blood pressure cuff on the arm and a Colin 7000 tonometric sensor (Colin
medical instruments, San Antonio, TX) on the wrist to measure blood pressure
continuously throughout the protocol. This was also interfaced with the Biopac MP100
and the data was collected at 200 hz. For a visual representation of the set-up for
testing the right arm see appendix C diagram C.1.
Baseline forearm blood flow measurements were obtained from the arm to be
exercised. Immediately before the blood flow measurements, hand circulation was
occluded for 1 minute by inflating the cuff at the wrist to 240 mmHg. The arm cuff was
then inflated to 50 mmHg and the baseline blood flow measurement was recorded.
Following the resting blood flow measure, the arm cuff was inflated to 200 mmHg for 3
minutes. One minute prior to release of the arm cuff, the wrist cuff was inflated to 240
mmHg. RHBF was recorded at an arm pressure of 50 mmHg.
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The participant was then asked to perform a handgrip exercise task preceded by
5 minutes of quiet rest (spontaneous breathing, SB1). The handgrip exercise task
consisted of squeezing a handgrip-measuring device once every two seconds at 60%
MVC while the cuff on the arm was inflated to 50 mmHg for 5 minutes (H60+50mmHg).
The participant had visual feedback regarding the amount of force they were exerting
and an auditory cue for the cadence. Additionally, they received verbal encouragement
to maintain the force and cadence.
Within the last 4 seconds of the exercising condition, the arm cuff was inflated to
200 mmHg for 3 minutes (FAO). Lastly, a blood flow measurement was obtained by
inflating the wrist cuff one-minute prior to the release of the arm cuff. The arm cuff
pressure was reduced to 50 mmHg and a blood flow measurement recorded.
Throughout the testing procedures, heart rate and blood pressure were recorded. The
testing procedures described above were repeated using the opposite arm as the
working arm. The testing procedures for both arms lasted approximately 150 minutes.
For a visual representation of the protocol time line see appendix C diagram C.2.
Following testing, each participant was randomized to either non-dominant arm
exercise training (training group) or the no training group.

The no training group

(external control group) refrained from activities that specifically exercised the forearm
muscles for 4 weeks.
3.3.2 Exercise Training
Participants reported to room 20 in the Gym Armory 4 days per week for 4
weeks. Each day, the participant's resting maximal voluntary contraction in the nondominant arm was measured using a Lafayette instrument handgrip dynamometer. The
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participant was asked to perform a handgrip exercise for 20 minutes with their nondominant arm. The handgrip exercise task consisted of squeezing a handgripmeasuring device once every two seconds at 60% of their resting MVC. Participants
were required to have an attrition rate of no less than 85%.
3.3.3 Session 2
Following 4 weeks of exercise training or the control period the participants
repeated the protocol outlined in session 1.
3.4 Data Treatment
3.4.1 Blood Flow Analysis
Blood flow was calculated as the rate of arterial inflow and reported in milliliters
per minute per 100 milliliters of tissue (ml/100 ml/min). Additionally, the change in blood
flow from baseline to RHBF was calculated (delta BF=RHBF-baseline).

Vascular

resistance was also calculated for the baseline and RHBF conditions as MAP/ blood
flow. The MAP collected during the SB1 condition was used for this calculation (taken
approximately 90 seconds after the RHBF blood flow measurement).
3.4.2 Pneumotachometer Data Analysis
Pneumotachometer data was analyzed using Acqknowledge 3.0 software.
Respiratory rate was obtained by counting the number of breathing cycles in a 15
second period and multiplying this number by 4 to report the data in breaths per minute.
The 15-second period was within the data segment described below for ECG and blood
pressure wave analysis.
For pre and post comparisons the data was expressed as an absolute change in
respiratory rate from spontaneous breathing values. Absolute change was calculated
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by subtracting the value obtained during exercise or forearm occlusion from values
obtained during spontaneous breathing (absolute change with exercise = value during
exercise - value during spontaneous breathing; absolute change with forearm occlusion
= value during forearm occlusion - value during spontaneous breathing).
3.4.3 ECG Analysis
The ECG data was analyzed using Acqknowledge 3.0 software. The ECG data
was visually inspected for non-sinus beats and converted to a tachogram of R-R period.
A custom made program in Matlab was used to analyze 2.2-minute segments of
tachogram data for frequency and time domain parameters. Tachogram segments were
taken from a representative section of data at least 90 seconds into the data collection
of spontaneous breathing and H60+50mmHg; and sampled from the first 2.5 minutes of
FAO.
Raw data was reported as mean heart period (mean R-R), standard deviation of
the normal sinus R-R intervals (SDNN), low frequency power (LF: 0.04 hz to 0.15 hz)
and high frequency power (HF: 0.15 hz to 0.40 hz).

The frequency domain was

additionally reported in normalized frequency units (LFnu: power / sum of LF + HF). For
pre and post comparisons the data was expressed as an absolute change in Mean R-R,
SDNN, LFnu from spontaneous breathing values. The formula was absolute change
with exercise (∆H60+50mmHg) = value during exercise - value during spontaneous
breathing and absolute change with forearm occlusion (∆FAO) = value during forearm
occlusion - value during spontaneous breathing).
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3.4.4 Blood Pressure Analysis
The blood pressure wave data was be analyzed using Acqknowledge 3.0
software. Mean arterial pressure (MAP) was obtained by taking the mean of a 2.2minute blood pressure wave segment taken after the first 90 seconds of recording of
spontaneous breathing and H60+50mmHg.

The 2.2-minute segment for FAO was

obtained during the first 2.5-minutes of the recording.
Using the segments described above, the data was also analyzed for the mean
of the maximum blood pressure wave peak (systolic blood pressure, SBP) and the
mean of the minimum blood pressure wave peak (diastolic blood pressure, DBP). For a
diagram of the parts of a blood pressure wave see appendix C diagram C.3.
For pre and post comparisons the data was expressed as an absolute change in
the condition (H60+50mmHg or FAO) from spontaneous breathing values. Absolute
change was calculated by subtracting the value obtained during H60+50mmHg
(∆H60+50mmHG) or forearm occlusion (∆FAO) from values obtained during
spontaneous breathing (∆H60+50mmHG = value during H60+50mmHg - value during
spontaneous breathing; (∆FAO = value during FAO - value during spontaneous
breathing).
3.5 Statistical Analysis
3.5.1 Participant Characteristics and Blood Flow
A one-way ANOVA was used to evaluate pre-test between group differences in age,
height, weight.

Additionally a one-way ANOVA was used to evaluate pre-test

differences in the non-dominant arm between groups in arm circumference (sites 1-4),
MVC, baseline blood flow, RHBF, delta blood flow, and vascular resistance. A one-way
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repeated measures ANOVA was used to evaluate pre-test differences between arms
(dominant versus non-dominant) in the Training group for arm circumference (sites 1-4),
MVC, baseline blood flow, RHBF, and delta blood flow. The effect of the treatment
between groups were evaluated in arm circumference and MVC using a 2 x2 mixed
model ANOVA for arm circumference (sites 1-4), MVC, baseline blood flow, RHBF, and
delta BF (See table 3.1).
Table 3.1: Statistical comparison for treatment effect between groups using raw data
2 levels of factor
Pre
Post
Non-dominant external control group

Raw data

Raw data

Non-dominant Training group

Raw data

Raw data

The effect of the treatment within the training group was evaluated in arm
circumference, MVC, and blood flow using a 2 x2 mixed model ANOVA for arm
circumference (sites 1-4), MVC, baseline blood flow, RHBF, and delta blood flow. See
table 3.2.
Table 3.2: Statistical comparison for treatment effect within groups using raw data
2 levels of factor
pre
post
Non-dominant arm

Raw data

Raw data

Dominant arm

Raw data

Raw data

3.5.2 Respiratory Rate, HRV, and Blood Pressure
A 3x2 mixed-model ANOVA was used to evaluate pre-test differences among the
conditions (SB1, H60+50mmHg, FAO) within groups in respiratory rate, mean R-R,
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SDNN, LFnu (statistics were run using the natural log of LFnu due to the non-normal
characteristics of the data), MAP, SBP, and DBP (table 3.3 and 3.4).
Table 3.3: Statistical comparison for the effect of condition in the Training group on pre
data only.
3 condition (repeated measures)
2 levels of factor

SB1

H60+50mmHg

FAO

Non-dominant

Raw data

Raw data

Raw data

Dominant

Raw data

Raw data

Raw data

Table 3.4: Statistical comparison for the effect of condition in the external control group
on pre-test data only.
3 condition (repeated measures)
2 levels of factor

SB

H60+50mmHg

FAO

Non-dominant

Raw data

Raw data

Raw data

Dominant

Raw data

Raw data

Raw data

A 2x2 mixed model ANOVA was used to evaluate the within group treatment effect
using ∆H60 and ∆FAO for respiratory rate, mean R-R, SDNN, LFnu, MAP, SBP, and
DBP (table 3.5).
Table 3.5: Statistical comparison for within group treatment effect using change in
absolute values from SB1 to H60+50mmHg or FAO
2 conditions (repeated measures)
2 levels of factor

Pre

Non-dominant arm

∆H60 or ∆FAO ∆H60 or ∆FAO

Dominant arm

∆H60 or ∆FAO ∆H60 or ∆FAO
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Post

Additionally, the treatment effect between groups was evaluated using a 2x2
(pre/post, non-dominant training group arm /non-dominant external control arm) mixed
ANOVA using ∆H60 and ∆FAO for respiratory rate, mean R-R, SDNN, LFnu, MAP,
SBP, and DBP (table 3.6).
Table 3.6: Statistical comparison for treatment effect between groups using change in
absolute values from SB1 to H60+50mmHg or FAO
2 levels of factor
Pre
Post
Non-dominant training group

∆H60 or ∆FAO

∆H60 or ∆FAO

Non-dominant external control

∆H60 or ∆FAO

∆H60 or ∆FAO

Alpha was set a priori at 0.05. A Tukey's protected T-test was used for post hoc
analysis. For the variables LFnu and MAP during ∆H60 and ∆FAO, post hoc analyses
were performed to determine the observed type II error rate for the main effect of group,
treatment, and the interaction. These are found in Appendix F.
3.5.3 Associations Among Variables
We evaluated the pre-test data for relationships among forearm circumference
(site 1) and the absolute magnitude of change in the cardiovascular parameters (as
compared to the SB1 condition, i.e., ∆H60+50mmHg and ∆FAO) for the variables Mean
R-R interval, SDNN, LFnu, and MAP. We used linear regression modeling employing
the least squares technique. Alpha was set a priori at 0.05.
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CHAPTER 4 RESULTS
4.1 Participant Characteristics
21 men and 19 women were recruited for participation in this study.

Nineteen

participants were assigned to the external control group and 21 were assigned to the
training group. Over the course of the study, 3 participants were removed from the
control group (1 woman and 2 men) and 2 participants were removed from the training
group (2 men) due to non-compliance with the pre-test instructions or non-compliance
with the training protocol.

There were no significant differences in participant

characteristics between non-compliers and those who completed the study. Table 4.1
summarizes the final participant characteristics (taken at pre-test) for the groups.
Table 4.1: Participant characteristics
External control

Training

Training

(n=16)

(n=19)

(n=19)

Non-dominant

Non-dominant

Dominant

Men/Women

8/8

9/10

Age

20.07±1.75

20.63±0.83

Height (inches)

67.80±2.91

67.47±4.76

Weight

161.53±28.57

168.89±34.07

Arm circ site 1 pre(cm)

26.10±2.64

26.58±3.31

27.21±3.30

Arm circ site 2 pre

23.30±2.37

23.13±3.32

24.26±3.35

Arm circ site 3 pre

18.87±2.08

18.86±2.17

18.91±2.21

Arm circ site 4 pre

16.28±1.24

16.68±1.56

16.45±1.37

MVC pre (peak torque)

69.10±24.15

71.77±35.72

78.90±33.90
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The external control and training group were well matched, inasmuch as there
were no group differences in age, height, weight, non-dominant arm circumferences,
and MVC. In addition there were no differences between dominant and non-dominant
arm circumferences, and MVC within the training group.
4.2 EPR effect (pre-data only)
4.2.1 Respiratory Rate, HRV, and Blood Pressure
There were no main effects of group or test condition (SB1, H60+50mmHg, and
FAO) on respiratory rate (see figure 4.1). However, there was a group by condition
interaction such that respiratory rate was elevated above SB1 and FAO during
H60+50mmHg, but only in the Training group during non-dominant arm exercise
(H60+50mmHg = 19.58±5.56 vs. SB1 = 16.76±3.15 and FAO = 16.56±5.85

Respiratory rate (breaths/min)

35

*

30

+

25
20
15
10
5
0
SB1

H60+50mmHg

FAO

Figure 4.1: Individual responses for respiratory rate to the
conditions in the non-dominant arm of the training group (pretest). The bold line indicates the mean of the group. * p<0.05
from SB1; +p<0.05 from H60+50mmHg
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breaths/min; p<0.05).

Consequently, respiratory rate was used as a covariate in

subsequent analyses of pretest data (Mean RR, SDNN, LFnu). There was no main
effect of group on Mean R-R, SDNN, LFnu, MAP, SBP, or DBP. However, there was a
main effect of test condition on Mean R-R, SDNN, LFnu, MAP, SBP, and DBP. Figure
4.2 to 4.4 represents the individual responses in the training group in the non-dominant
arm pre-training to SB1, H60+50mmHg, and FAO for the variables mean R-R, LFnu,
and MAP.
Post-hoc tests revealed that SDNN decreased during H60+50mmHg and
returned to baseline with FAO for all groups.

See table 4.2 (H different from

H60+50mmHg and * different from SB1). Likewise, LFnu and SBP increased during
H60+50mmHg and returned to baseline during FAO for all groups (see table 4.3 for
SBP results; H different from H60+50mmHg and * different from SB1).

*

1300
Mean R-R (miliseconds)

1200

*
+

1100
1000
900
800
700
600
500
400
SB1

H60+50mmHg

FAO

Figure 4.2: Individual responses for mean R-R to the conditions
in the non-dominant arm of the training group (pre-test). The
bold line indicates the mean of the group. * p<0.05 from SB1;
+p<0.05 from H60+50mmHg
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LFnu (%)

*
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SB1

H60+50mmHg

+

FAO

Figure 4.3: Individual responses for LFnu to the conditions in
the non-dominant arm of the training group (pre-test). The bold
line indicates the mean of the group. * p<0.05 from SB1;
+p<0.05 from H60+50mmHg

200

*

*

180

MAP (mmHg)

160
140
120
100
80
60
40
20
0
SB1

H60+50mmHg

FAO

Figure 4.4: Individual responses for MAP to the conditions in
the non-dominant arm of the training group (pre-test). The bold
line indicates the mean of the group. * p<0.05 from SB1;
+p<0.05 from H60+50mmHg
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Table 4.2: The effect of condition on SDNN by group and arm (pre-test only).
SDNN (miliseconds)
External control
Training
Training
(n=16)

(n=19)

(n=18)

Non-dominant

Non-dominant

Dominant

SB1

88.62±41.94

90.85±40.46

85.76±25.70

H60+50mmHg

45.69±20.41*

46.96±15.07*

49.84±30.87*

FAO

117.51±80.84H

87.14±42.02H

98.15±47.30H

Mean±standard deviation
Table 4.3: The effect of condition on SBP by group and arm (pre-test only).
SBP (mmHg)
External control
Training
Training
(n=16)

(n=19)

(n=20)

Non-dominant

Non-dominant

Dominant

SB1

122.80±22.88

125.29±28.27

117.55±24.41

H60+50mmHg

150.39±29.34*

142.77±43.56*

142.80±30.85*

FAO

137.61±32.87

141.22±43.65

137.61±24.28

Mean±standard deviation
In the case of MAP, however, the post-hoc tests indicated that the values
increased during H60+50mmHg and remained elevated during FAO (see figure 4.4).
The main effects on mean R-R and DBP are modified by the appearance of group by
test condition interactions (see table 4.4 for DBP results; H different from H60+50mmHg
and * different from SB1).
Similar to SDNN, the values for Mean R-R were lower during H60+50mmHg as
compared to SB1 for all groups (see figure 4.2). However, while the values tended to
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Table 4.4: The effect of condition on DBP by group and arm (pre-test only).
DBP (mmHg)

External control

Training

Training

(n=16)

(n=19)

(n=20)

Non-dominant

Non-dominant

Dominant

SB1

69.69±25.10

68.54±18.52

56.82±19.37

H60+50mmHg

86.96±22.23*

76.39±27.07*

76.86±21.18*

FAO

77.50±27.70

79.52±30.24*

71.25±22.92*

Mean±standard deviation
return to baseline (SB1) during FAO, only the external controls returned completely to
baseline. With respect to DBP, the values increased during H60+50mmHg, and tended
to return to baseline during FAO, but only completely recovered in the external control
group.
4.2.2 Associations Among Variables
Additionally, we chose to evaluate the pre-test data for relationships among
forearm circumference (site 1) and the absolute magnitude of change in the
cardiovascular parameters (as compared to the SB1 condition), i.e., ∆H60+50mmHg
and ∆FAO for the variables Mean R-R interval, SDNN, LFnu, and MAP. We found no
associations between circumference site and the ∆conditions for the variables SDNN or
LFnu. However, ∆H60+50mmHg for the variable mean R-R was associated (Dominant
arm (D): p=0.03, R2=0.14; non-dominant arm (ND): p=0.001, R2=0.26) with forearm
circumference (slope: D=-14.79 msec*cm, ND=-22.11 msec*cm), where a larger
decrease in mean R-R from SB1 to H60+50mmHg was associated with a larger arm
circumference. See figure 4.5 for a scatter plot of the data with the regression line.
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Change in Mean R-R from SB1 to H60+50mmHg (msec)

dominant arm
non-dominant arm
Y=-14.79(circ)+180.48, R2=0.14,
p=0.03
0
-100
-200
-300
-400
-500
-600
20

22

24

26

28

30

32

34

arm circumference (cm)
Figure 4.5: Scatter plot and the linear regression for the association
between forearm circumference and the change in Mean R-R from SB1 to
H60+50mmHg.
There was also a significant association between ∆FAO for mean R-R to forearm

circumference with (ND: p=0.03, R2=0.13; slope=14.11msec*cm), where mean R-R
recovered to baseline levels more quickly with a larger arm circumference. See figure
4.6 for a scatter plot of the data with the regression line.
Additionally, there was a significant positive correlation (slope=2.17 mmHg*cm)
between the ∆H60+50mmHg for MAP (dominant arm) and forearm circumference
(p=0.04, R2=0.13). See figure 4.7. ∆FAO for MAP was also associated with (slope: D=2.11 mmHg*cm) forearm circumference (D: p=0.03, R2=0.15). See figure 4.8 for a
scatter plot of the data with the regression line included.
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non-dominant arm

300

Y=14.11(circ)-288.90, R2=0.13,
p=0.03
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Figure 4.6: Scatter plot and the linear regression for the association
between forearm circumference and the change in Mean R-R from SB1 to
FAO.
Change in MAP from SB1 to H60+50mmHg (mmHg)

Change in Mean R-R from SB1 to FAO (msec)

dominant arm
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dominant arm
non-dominant arm
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Figure 4.7: Scatter plot and linear regression for the association between
forearm circumference and the change in MAP from SB1 to
H60+50mmHg.
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Change in MAP from SB1 to FAO (mmHg)
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Figure 4.8: Scatter plot and the linear regression for the association
between forearm circumference and the change in MAP from SB1 to
FAO.
4.3 Effect of Training
4.3.1 Participant Characteristics
There were no main effects of treatment period or group by treatment period
interactions on arm circumference at any site or handgrip MVC. Data is summarized in
table 4.5.
4.3.2 Blood Flow and Vascular Resistance
The results of the mixed-model ANOVA revealed no main effect of treatment or
group by treatment interactions for any of the blood flow or vascular resistance
parameters (baseline, or during reactive hyperemia). However, when a paired T-test
was run on the non-dominant arm of the training group (i.e., the trained arm) there was
a significant decrease in vascular resistance during RHBF with training (p=0.03). A
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summary of individual response to the control condition in the dominant arm in figure
4.9, and training in the non-dominant arm is in figure 4.10.
Table 4.5: The effect of treatment for arm circumference and MVC
External control
Training

Arm circ site 1 (cm)

Arm circ site 2 (cm)

Arm circ site 3 (cm)

Arm circ site 4 (cm)

Training

(n=16)

(n=19)

(n=19)

Non-dominant

Non-dominant

Dominant

pre

26.10±2.64

26.58±3.31

27.21±3.30

post

26.10±2.74

26.63±3.32

27.21±3.30

pre

23.30±2.37

23.13±3.32

24.26±3.35

post

23.50±2.98

23.42±3.22

24.26±3.35

pre

18.87±2.08

18.86±2.17

18.91±2.21

post

18.83±2.13

18.58±2.13

18.91±2.21

pre

16.28±1.24

16.68±1.56

16.45±1.37

post

16.20±1.08

16.53±1.56

16.45±1.37

pre

69.10±24.15

71.77±35.72

78.90±33.90

post

70.99±23.50

75.80±31.10

77.47±29.61

MVC post (peak torque)

Mean±standard deviation
4.3.3 Respiratory Rate, HRV, and Blood Pressure
Two separate 2 x 3 mixed model ANOVAs were conducted to examine main
effects of group and treatment period and group by treatment period interactions on the
∆H60+50mmHg and the ∆FAO for the variables respiratory rate, Mean R-R interval,
SDNN, LFnu, MAP, SBP, and DBP.

One ANOVA included the internal control
69

(dominant arm of the training group), while the other employed the external control
(Non-dominant arm of external control group).
The results of the ANOVAs, in either case, revealed no main effects of group nor
treatment period, nor group by treatment period interactions on any of the ∆conditions
for the parameters indicated. The means and standard deviations for the groups are

Vascular Resistance (mmHg/ml/100 ml/min)

summarized in tables 4.6 to 4.12.

9.00
8.00
7.00
6.00
5.00
4.00
3.00
2.00
1.00
0.00
Pre

Post

Figure 4.9: Individual responses for the change in vascular
resistance during RHBF before (pre) and after (post) the
control period in the dominant arm of the training group.
Figure D.1 to D.3 in appendix D represents the individual responses in the
Training group in the non-dominant arm during FAO pre-training and post training for
Mean R-R, LFnu, and MAP.

Additionally, post-test absolute values for SB1,

H60+50mmHg, and FAO are summarized in tables E.1 through E.7 in appendix E.
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Vascular resistance (mmHg/ml/100ml/min)

9.00
8.00

*

7.00
6.00
5.00
4.00

*

3.00
2.00
1.00
0.00

Pre
Post
.
Figure 4.10: Individual responses for the change in vascular
resistance during RHBF before (pre) and after (post) training in
the non-dominant arm of the training group. * p=0.03 using a
paired T-test different from pre-test.

Table 4.6: The effect of treatment on respiratory rate by group and arm.
respiratory rate
External control
Training
Training
(breaths/min)

(n=14)

(n=17)

(n=17)

Non-dominant

Non-dominant

Dominant

2.42±6.23

3.59±4.87

4.26±6.51

post

3.50±6.36

4.00±5.34

3.53±5.17

pre

-0.50±4.25

0.18±5.33

1.00±4.49

post

2.07±4.01

1.41±4.73

0.78±4.86

∆H60+50mmHg pre

∆FAO

Mean±standard deviation
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Table 4.7: The effect of treatment on mean R-R by group and arm
mean R-R (msec)
External control
Training
(n=15)

(n=19)

(n=19)

Non-dominant

Non-dominant

Dominant

-255.48±153.64

-240.83±112.31

-229.63±102.62

post

-221.33±97.34

-236.18±146.03

-223.52±131.00

pre

75.21±119.43

93.38±115.35

52.83±135.83

post

59.74±96.28

83.44±109.70

35.95±136.90

∆H60+50mmHg pre

∆FAO

Training

Mean±standard deviation
Table 4.8: The effect of treatment on SDNN by group and arm
SDNN (msec)
External control
Training

∆H60+50mmHg pre

∆FAO

Training

(n=15)

(n=19)

(n=19)

Non-dominant

Non-dominant

Dominant

-41.63±39.51

-47.80±42.30

-34.95±40.36

post

-52.43±42.59

-41.00±34.19

-49.60±33.61

pre

-29.23±76.91

6.29±27.45

12.25±103.17

post

-2.39±53.17

-9.23±30.27

-9.87±39.80

Mean±standard deviation
While there were no statistically significant main or interaction effects noted,
there appeared to be a trend toward a treatment by group interaction for SDNN
(p=0.08). The mean decrease in SDNN observed in the trained arm was of a smaller
magnitude after the training period, whereas in the internal and external control arms,
the mean decrease in SDNN was of a greater magnitude following training (see table
4.8). We also found a trend toward a main effect of treatment in SBP (p=0.08), where
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both groups (non-dominant arm) decreased ∆H60+50mmHg from pre- to post-test (see
table 4.11).

Lastly, we found a trend towards a treatment by arm interaction with

∆H60+50mmHg in DBP (p=0.08). In the training group, DBP increased from pre- to
post-test in the non-dominant arm, but decreased in the dominant arm with
∆H60+50mmHg (see table 4.12).
Table 4.9: The effect of treatment on LFnu by group and arm.
LFnu (%)
External control
Training
(n=15)

(n=19)

(n=19)

Non-dominant

Non-dominant

Dominant

18.71±14.04

19.33±15.59

11.74±16.24

post

13.57±17.66

20.74±19.97

8.66±23.39

pre

4.63±20.85

-6.66±14.72

2.03±18.70

post

-1.61±18.27

-6.16±17.40

2.83±20.78

∆H60+50mmHg pre

∆FAO

Training

Mean±standard deviation
Table 4.10: The effect of treatment on MAP by group and arm
MAP (mmHg)
External control
Training
(n=14)

(n=19)

(n=16)

Non-dominant

Non-dominant

Dominant

30.42±22.06

19.26±19.42

23.20±20.09

post

17.47±12.17

19.42±13.93

16.99±13.22

pre

19.44±21.53

18.74±20.09

12.89±21.30

post

15.09±13.16

14.06±19.52

10.26±20.73

∆H60+50mmHg pre

∆FAO

Training

Mean±standard deviation
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Table 4.11: The effect of treatment on SBP by group and arm
SBP (mmHg)
External control
Training
(n=14

(n=18)

(n=16)

Non-dominant

Non-dominant

Dominant

27.59±24.58

18.28±25.52

25.26±24.49

post

13.44±13.13

13.64±18.20

14.93±17.27

pre

14.81±28.25

16.85±27.23

20.07±26.05

post

10.85±11.19

8.99±24.73

15.79±20.39

∆H60+50mmHg pre

∆FAO

Training

Mean±standard deviation
Table 4.12: The effect of treatment on DBP by group and arm
DBP (mmHg)
External control
Training
(n=14)

(n=18)

(n=16)

Non-dominant

Non-dominant

Dominant

22.28±21.72

8.86±20.42

20.04±16.21

post

16.99±11.25

17.38±13.62

15.17±11.52

pre

12.29±25.01

9.82±22.60

14.43±17.31

post

12.55±13.02

7.79±17.92

12.13±12.34

∆H60+50mmHg pre

∆FAO

Training

Mean±standard deviation
4.3.4 Other Measurements
Participants did improve their training time from the first week (average training time:
17±5minutes) to the last week (20±2minutes, the training time was limited to 20 minutes
per session, p<0.05). Additionally, participants reported an average RPE of 13±2 the
first week and 15±8 the last week of training (not significant).
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CHAPTER 5 DISCUSSION
The purpose of this study was twofold: (1) to examine the cardiovascular
response to an acute bout of handgrip exercise in as much as it may be reflective of
stimulation of the EPR; and (2) to evaluate the influence of non-dominant handgrip
exercise training on cardiovascular response to exercise and post-exercise forearm
occlusion.

The results indicate that we were successful in establishing a model with

cardiovascular responses consistent with stimulation of the EPR. With respect to the
influence of exercise training, we hypothesized that exercise training would result in
attenuated HRV and blood pressure responses to exercise (H60+50mmHg) and
recovery (FAO) in the trained arm. Exercise training did not result in an attenuated HRV
and blood pressure response to H60+50mmHg and FAO.
5.1 Participant Characteristics
Our participants were well matched for gender, age, height, weight, forearm
circumferences, and MVC such that there were no significant differences in these
variables between groups for the pre-test.

Additionally there were no significant

differences between the dominant and non-dominant arms with respect to MVC and
forearm circumferences at pre-test. This is in agreement with Mostoufi-Moab et al.
(1998), Somers et al., 1992, and Sinoway et al., 1996 that showed no significant
difference in MVc or forearm circumference between dominant and non-dominant arms.
Our forearm circumference measurements (Non-dominant arm site 1: 26.58±3.31cm;
site

2:

23.13±3.32cm;

site

3:

18.86±2.17cm)

were

consistent

with

forearm

circumferences reported by Sinoway et al., 1996 (Non-dominant arm site 1:
27.6±0.50cm; site 2: 24.5±0.5cm; site 3: 19.4±0.4cm).
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5.2 EPR Effect
5.2.1 Respiratory Rate, HRV, and Blood Pressure
Respiratory rate did increase significantly during H60+50mmHg (≈+2.82 breaths
per minute). This is consistent with results from Fontana et al. (1994) that found an
approximate 4 breath per minute increase in respiratory rate with isometric handgrip
activity. In this study, respiratory rate during post-exercise forearm occlusion was not
significantly different from SB1.

To our knowledge there are no previous studies

measuring respiratory rate during forearm occlusion. Due to the possibility that HRV
measurement may be effected by a change in respiratory rate, it was subsequently
used as a covariate for the EPR effect analyses.
We found approximately a 20 beat per minute increase (Mean R-R≈233.11msec)
in heart rate during H60+50mmHg. This was consistent with Victor et al. (1987) which
found a 13 beat per minute increase in heart rate during dynamic handgrip exericse at
30% MVC (0.7hz) with 50mmHg on the arm and Mostoufi-Moab et al. (1998) that found
a 12 beat per minute increase in heart rate with dynamic handgrip exericse at 25%MVC
(0.25hz) with 50mmHg of pressure on the arm. During FAO, mean R-R decreased
below H60+50mmHg, but remained significantly elevated above SB1 (≈6beats per
minute). This is in contrast to findings by Somers et al. (1992), Iellamo et al. (1999),
Fisher and White (1999), Victor et al. (1987), Seals (1989), Victor and Seals (1989), and
Strange (1999) which found that heart rate during FAO was not significantly different
from SB1.

One reason for this discrepancy is the method by which heart rate was

measured. In the current study we used the mean R-R interval as a measurement of
heart period as opposed to mean heart rate used in the studies listed above. From
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previous work in this lab we have determined that the standard error of the mean for
Mean R-R interval is less than 56 miliseconds, thereby allowing us to detect small
changes in heart period (Kluess et al., 2002). Although not reported as significantly
different from SB1, the reported mean differences between FAO and SB1 for the above
mentioned studies (2 and 5 beat per minute higher heart rates during FAO), were
similar to the magnitude of change reported in this study (≈6 beats per minute),
There have been no previous studies reporting SDNN change during
H60+50mmHg. However, the SDNN at SB1 was similar to a previous study in this lab
using similar participant demographics and tachogram time period for analysis (Kluess
et al., 2002). Additionally, the magnitude of change in SDNN with H60+50mmHg in the
current study was 1.5-fold greater than in our previous study where there was no
forearm occlusion during exercise (Kluess et al., 2002). SDNN returned to SB1 levels
during FAO which was an expected change considering that SDNN calculated for less
than five minutes is believed to more strongly reflect changes in parasympathetic
activity (Task force, 1996, Kluess et al., 2000).
For the variables LFnu and MAP the following discussion will focus on the
behavior of these variables in reference to the hypotheses regarding cardiovascular
responses consistent with stimulation of the EPR and comparison to other literature.
Post-exercise occlusion is commonly employed to quantify the EPR (McClosky
and Mitchell, 1972; Victor et al., 1987; Hayward, Wesselmann, Rymer, 1991; Somers et
al., 1992; Seals, 1989; Victor and Seals, 1989; Fisher and White, 1999; Strange, 1999).
The theory is that if EPR plays a significant role in the muscle sympathetic and
cardiovascular responses to exercise, then occluding the blood flow to the muscle after

77

cessation of the exercise will result in a persistent elevation of muscle sympathetic
activity and blood pressure due to continued stimulation of group IV afferents by the
metabolites trapped in the muscle (Victor and Seals, 1989).
This effect has been demonstrated in both isometric and dynamic exercise using
afferent, efferent, and end-organ models (Seals, 1989; Somers et al., 1992; Victor and
Seals, 1989). Our finding that MAP was elevated above SB1 during FAO is consistent
with the idea that our exercise protocol (H60+50mmHg) sufficiently stimulates the EPR.
However, we also expected to see an elevation in LFnu, an index of sympathetic
activity, during FAO. Despite an elevation of LFnu during H60+50mmHg, LFnu did not
remain elevated above SB1 during FAO.
The present findings initially appear to stand in contrast to Iellamo et al. (1999)
who found a persistent elevation in low frequency power (ms2) and low frequency
normalized units during post-exercise occlusion. Interestingly, however, the change
from spontaneous breathing (LFnu=63.8%) to exercise (LFnu=82.8%) in Iellamo et al.
(1999) was similar to that of the present study (pre-train non-dominant arm LFnu
SB1=53.43%; H60=73.62%).

The statistical significance observed in Iellamo, et al.

(1999) might have been aided by their use of isometric single-leg exercise, while the
present study employed dynamic handgrip exercise. The use of a larger muscle mass
and an isometric challenge may have provided a greater stimulus for an EPR response.
The effect of muscle group size on sympathetic activity has been previously
studied by Seals (1993) who showed that the MSNA, heart rate, and blood pressure
responses to isometric handgrip exercise were greater than that for isometric finger
flexion exercise, despite relative intensity and perceived effort being the same. This
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relationship between muscle group size and magnitude of cardiovascular and
sympathetic response to exercise also holds for dynamic exercise. Victor et al. (1987)
had their participants perform dynamic handgrip exercise at 30%MVC which caused a
5-b/min increase in heart rate and a 7-mmHg increase in MAP, but no change in MSNA
(Victor et al., 1987). However, arm cycling exercise at 30% of max resulted in a 32b/min increase in heart rate, a 12-mmHg increase in MAP, and a 25 burst/minute
increase in MSNA (Victor and Seals, 1989).
Further, when these findings are paired with post-exercise occlusion to
specifically target the EPR, leg activity (dynamic or isometric) always results in
persistent elevation of blood pressure during post-exercise occlusion (Iellamo et al.,
1999; Fisher and White, 1999; Strange, 1999). However, dynamic handgrip exercise
only induces persistent elevation of blood pressure when the intensity is at least
60%MVC (1hz contraction speed) or the forearm is occluded during the activity (Victor
and Seals, 1989; Victor et al., 1987). Therefore, the muscle group exercised appears to
play a role the cardiovascular and autonomic response to exercise and the ability of
HRV to detect these changes.
The mode by which this change in signals from parasympathetic withdrawal
during activity to an increase in parasympathetic activity during recovery, despite
continued EPR signaling, is not entirely understood. It is known that dynamic exercise
increases the activity of both group III and IV afferents, however, group III afferents are
mostly inactive during post-exercise occlusion.
Work by Potts and Mitchell (1998) suggests that the movement detection (group
III afferents) aspect of the EPR influences baroreceptor resetting during exercise and
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therefore, when that stimulus is removed the barorecepetor reflex acts to slow heart
rate.

Regardless of the specific mechanism, it is plausible that since the skeletal

muscle vasculature does not contain parasympathetic innervation, MAP remains high
as a consequence of heightened sympathetic activity. However, in the heart, where
vagal activity has a dramatic chronotropic effect, spectral parameters of HRV may not
provide a clear measure of sympathetic changes. This is particularly true during periods
where both sympathetic and parasympathetic activity is elevated above the baseline (or
comparison condition).

The reason for this is that LFnu is calculated as LF power in

relation to the change in HF power. Therefore a decrease in LFnu during FAO can
indicate any one of the following: 1) an increase in HF with no change in LFpower; 2) an
increase in HF with a decrease in LF power, or 3) an increase in the power of both HF
and LF power such that the magnitude of change in HF power is greater than the
change in LF power.
As mentioned, the present investigation involved dynamic exercise, while Iellamo
et al. (1999) employed isometric work.

It has been well established that isometric

exercise induces greater sympathetic, heart rate, and blood pressure response
compared to dynamic activity at the same workload (Gonzalez-Camarena et al., 2000).
However, there is evidence that the cardiovascular and autonomic response to
isometric and dynamic exercise is not the same. Gonzalez-Camarena et al. (2000)
compared the HRV response of isometric (30%MVC) and dynamic (30 to 60%VO2max,
60 rpm, 6 min) quadriceps femoris exercise. They controlled for both exercise intensity
(%MVC) and MAP at peak exercise and found that dynamic exercise resulted in an
overall reduction in HRV power (ms2) and a shift toward the LF domain indicating that
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the exercise induced parasympathetic withdrawal and an increase in sympathetic
modulation of the heart. However, isometric exercise resulted in an overall increase in
HRV power (ms2) with both an increase in LF and HF power, indicating that there was
an increase in parasympathetic and sympathetic modulation of the heart.

They

concluded that the cardiovascular responses to isometric and dynamic exercise are not
controlled through the same mechanisms and speculated that the baroreceptor reflex
may play a greater role in isometric compared to dynamic exercise. This conclusion is
substantiated by Potts and Mitchell (1998) who found that baroreceptor resetting during
exercise is influenced by the movement detection aspect of the EPR and therefore,
baroreceptor resetting may not occur to the same degree with a single isometric
contraction, compared to multiple dynamic contractions.
Differences in the muscle group exercised, exercise intensity, and exercise mode
all appear to alter the relative contribution of the different cardiovascular control
mechanisms during exercise and forearm occlusion. However, it also may be possible
to alter cardiovascular control mechanisms while controlling for the above variables. In
a previous study, our participants performed handgrip exercise at 60%MVC without
50mmHg (Kluess et al., 2001). Interestingly, the change in LFnu from rest to H60 with
50mmHg of forearm occlusion (Train non-dominant pre: 19.33%) were approximately
the same as our previous study where the participants performed H60 without forearm
occlusion (Kluess et al., 2001, control day: 21.20%). In the previous study (Kluess et
al., 2002), MAP did not remain elevated above SB1 during FAO, while in the current
study, this effect did occur. This finding is important and, according to EPR theory,
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suggests that forearm occlusion during exercise resulted in greater EPR activation than
the exercise alone.
Adreani and Kaufman (1998) using a decerebrate cat model have previously
demonstrated the effect of occlusion during exercise. They found that group III and IV
afferents were directly stimulated with simulated walking activity with and without
complete arterial occlusion. However, the magnitude of change in group III and IV
afferent firing frequency to activity with arterial occlusion was 44% and 47% higher,
respectively, than simulated walking without arterial occlusion.
In humans, exercise with reduced metabolite washout has also been used to
induce EPR activity. Mostoufi-Moab et al. (1998) used dynamic handgrip exercise at
25%MVC with and without 50 mmHg of pressure on the arm and found no elevation of
blood pressure with 25%MVC alone, but found a significant elevation in blood pressure
when occlusion was present.
Victor et al. (1987) demonstrated the EPR specificity of this maneuver in
humans. They performed dynamic handgrip exercise at 30% MVC with 50mmHg of
pressure on the arm and found that it resulted in approximately three-fold greater heart
rate and blood pressure response, compared to exercise with no pressure on the arm.
Additionally, they found a persistent elevation in blood pressure and MSNA during
forearm occlusion. This did not occur when dynamic handgrip exercise at 30%MVC
was performed without occlusion (Victor and Seals, 1989). They specifically attributed
the cardiovascular and muscle sympathetic nerve activity responses to greater
stimulation of the EPR through increased trapping of metabolites during the activity.
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Therefore, the contrast between the HRV findings from Illeamo et al. (1999) and
the current study are most likely explained by differences in muscle group size where a
larger muscle mass induces an EPR response that persists more completely into
forearm occlusion. Evidence from previous studies in this lab and others suggest that
despite similar increases in sympathetic activity during exercise it is possible to shift the
relative contribution of cardiovascular control mechanisms through trapping metabolites
during exercise, altering the mode of exercise, and exercising different muscle groups
(Iellamo et al., 1999; Gonzalez-Camarena et al, 2000; Kluess et al., 2002).
5.2.2 Associations Among Variables
It has been well established that the magnitude of the change in sympathetic
activity and, to some degree, the cardiovascular response to activity is related to the
muscle group recruited.

This inference has come primarily from studies that have

compared different muscle groups (e.g., arms vs. legs).

However, there is no

information concerning the relationship between muscle mass within the same muscle
group and cardiovascular and autonomic response to exercise.

Additionally, the

relationship between muscle mass and the cardiovascular response, as assessed
during post-exercise forearm occlusion has never been formally reported.
The working hypothesis for the relationships stated above is that a larger muscle
mass contains more group III and IV afferents and therefore, the afferent signal is larger
and signals a greater magnitude cardiovascular response than a smaller muscle mass
(Seals, 1993; Victor et al., 1987; Victor and Seals, 1989; Fisher and White, 1999;
Iellamo et al. 1999; Gonzalez-Camarena et al. 2000; Somers et al. 1992; Strange,
1999). Therefore we used linear regression to infer if a relationship existed among
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circumference site 1 (the site closest to the olecranon process) and the change from
SB1 to H60+50mmHg and the change from SB1 to FAO for the variables Mean R-R,
SDNN, LFnu, and MAP.
We found a negative relationship between arm circumference and change in
Mean R-R from SB1 to H60+50mmHg.

This was accompanied by a positive

relationship between arm circumference and increase in MAP from rest to
H60+50mmHg (dominant arm, pre-test). Both of these relationships are consistent with
the above stated hypothesis and suggest that a larger muscle mass (as inferred from
arm circumference) induces a greater cardiovascular response to exercise (of a given
relative intensity).
However, we found a positive relationship between forearm circumference and the
change in Mean R-R from forearm occlusion to SB1 (dominant arm). Additionally, we
found a positive relationship between MAP during forearm occlusion and forearm
circumference (dominant and non-dominant arm). Therefore, a person with a larger
arm circumference recovers to a higher heart period during forearm occlusion than
people with a smaller arm circumference.

The finding that cardiovascular recovery

(mean R-R) is more rapid with a larger arm circumference suggests that central
command plays a large role in the cardiovascular response to exercise, compared to a
smaller forearm circumference.
Although not previously explored, there is some evidence supporting this
supposition. Training studies in the arm have demonstrated that training adaptations
are localized to the arm used and attributed to changes in EPR (Somers et al., 1992;
Mostoufi-Moab et al., 1998; Sinoway et al., 1996). However, studies using leg training
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(single leg and both legs) have found significant changes in central command, but no
detectable changes in EPR (Fisher and White, 1999; Seals and Chase, 1989).
Although it is difficult to directly relate these chronic studies to the current acute study it
does set a precedent for larger muscle masses having a greater influence on central
command.
In contrast to Mean R-R, MAP remained higher with a larger muscle mass and is
consistent with the hypothesis that larger muscles have greater magnitude change
consistent with the EPR effect. The association between forearm circumference and
the behavior of Mean R-R and MAP during H60+50mmHg and FAO hypothetically
indicate that the EPR and central command are not entirely redundant mechanisms and
under certain circumstances can act in opposition to each other.
Uniquely, we found that the cardiovascular response to exercise and forearm
occlusion in a single muscle group is consistent with the idea that cardiovascular
response is subject to significant variation in the predominant mechanism of
cardiovascular control despite maneuvers to emphasize a single mechanism. These
findings further underscore the complexity of studying mechanisms of cardiovascular
control in humans.
5.3 The Effect of Training
The second part of this study was to evaluate the influence of non-dominant
handgrip exercise training on cardiovascular response to exercise and post-exercise
forearm occlusion. As expected, we saw no MVC, forearm circumference, blood flow,
respiratory rate, HRV, or blood pressure changes in the external control group (nondominant arm) and the dominant arm of the training group.
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However, the data did not support our hypothesis that exercise training would
result in attenuated HRV and blood pressure responses to exercise and FAO in the
trained arm. While it would be tempting to speculate that perhaps the training was not
sufficient to evoke an adaptation per-se, it should be noted that a reduction in vascular
resistance during RHBF in the trained arm was evident after the training period.
5.3.1 Participant Characteristics
There was no significant effect of training on MVC or forearm circumference at
any of the measured sites. This is consistent with results from Alomari et al. (2001),
Somers et al. (1992), Mostoufi-Moab et al. (1998), and Sinoway et al. (1996).
5.3.2 Blood Flow and Vascular Resistance
We hypothesized that RHBF would be significantly higher following handgrip
exercise training in the non-dominant arm.

In contrast to studies by Alomari et al.

(2001); Sinoway, Shenberger, Wilson, McLaughlin, Musch, Zelis (1987); and Green,
Cable, Fox, Rankin, Taylor (1994) we did not see a significant change in RHBF
following exercise training. However, when a paired T-test was run on the trained arm
(non-dominant), vascular resistance during RHBF was lower following the training
period. While providing only a weak inference, such a training adaptation would be
consistent with previous published data from our laboratory (Alomari et al., 2001).
5.3.3 Respiratory Rate, HRV, and Blood Pressure
There was no significant effect of training for respiratory rate and SDNN for
∆H60+50mmHg or ∆FAO. To our knowledge, there are no previous studies concerning
the changes in respiratory rate and SDNN under conditions similar to the current study.
While we did see a trend towards a training adaptation in SDNN, this parameter is
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primarily thought of as a marker of parasympathetic activity, and therefore it is not likely
to be addressing EPR per-se. Additionally, there was no training effect with Mean R-R
during either ∆H60+50mmHg or ∆FAO. This finding is in agreement with studies by
Mostoufi-Moab et al. (1998), Sinoway et al. (1996), and Somers et al. (1992) which also
found no difference in mean R-R at rest and during exercise.
In contrast to our hypothesis, the response of LFnu was not attenuated during
either ∆H60+50mmHg or ∆FAO following training. As discussed previously, our HRV
measurements under the conditions used during this study were complicated by two
main factors: a) the high vagal activity in the heart dampening the ability to see
peripheral sympathetic changes and b) a previously unreported association between
arm

circumference

and

predominant

cardiovascular

mechanism

complicated

interpretation of the data. As a result of these problems it was highly unlikely that we
would see the hypothesized attenuation of HRV response to the conditions.
Additionally, we calculated the type II error rate for LFnu during ∆H60+50mmHg
or ∆FAO (see appendix F).

This indicated that we had sufficient power to detect

changes with ∆H60+50mmHg, but with ∆FAO we had a 52% chance of a type II error.
The elevated type II error rate was likely due to nearly significant pre-test differences.
Regardless, this finding does not interfere with the inference that exercise training did
not attenuate the response in LFnu (See appendix F, tables F.3 and F.4).
However, in agreement with others, we did not see attenuation in HRV response
to the conditions in the dominant arm (Somers et al., 1992; Alomari et al., 2001;
Sinoway et al., 1996). No change in the dominant arm, despite training in the nondominant arm, does suggest that central command was not altered by our handgrip
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exercise training protocol. This finding is in contrast to Fisher and White (1999) that
found a change in central command using single leg training. These disparate findings
may be the result of differences in cardiovascular control by muscle group and size.
Despite the problems experienced with HRV variables we observed an EPR
effect during FAO in MAP and expected to see an attenuation of MAP response with
training. However, we observed no main effect of treatment for MAP. A post-hoc
calculation of the type II error rate revealed that we had a 34.7% chance of committing a
type II error on the treatment by group interaction (see appendix F). However, this
slightly elevated type II error rate does not weaken our inference about a lack of a
training effect in that the mean responses in MAP in the trained arm (non-dominant)
were very close in magnitude (Pre-test: 18.17mmHg; post-test: 19.21mmHg). No MAP
changes with handgrip exercise training is in contrast to studies by Sinoway et al.
(1996) and Mostoufi-Moab et al (1998) that report a decreased MAP during handgrip
exercise testing. There are several differences between the current study and those by
Sinoway et al. (1996) and Mostoufi-Moab et al. (1998) including the intensity of the
handgrip exercise, the length of time of the exercise bout, and the contraction speed.
The exercise intensity used during training and during testing in studies by
Mostoufi-Moab et al. (1998) and Sinoway et al. (1996) were much lower than that used
in the current study. However, Mostoufi-Moab et al. (1998) and Sinoway et al. (1996)
did have participants exercise to fatigue during the training sessions, while our
participants were limited to 20 minutes per training session. Despite the limitation in
time for our subjects, the initial exercise intensity was 2-fold greater than Sinoway et al.
(1996) and Mostoufi-Moab et al. (1998) and the first week most participants were
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fatigued (drop in force produced of more than 10 units) in under 20 minutes (average
training time for the first week was17±5 minutes). Additionally, the reported average
rating of perceived exertion for the first week of training was 15 (Hard) and for the last
week was 17 (very hard). These data, although weak, suggest that our training protocol
was fatiguing and perceived as effortful.

Therefore, it is difficult to explain the

differences in MAP results among studies exclusively to training intensity and exercise
session duration
Another

difference

between

this

study

and

previous

studies

is

the

contraction/relaxation speed during the training. Sinoway et al. (1996) and MostoufiMoab et al. (1998) used 2-second contraction to 3-second release for exercise training
and found a decrease in MAP during exercise testing.

However, studies such as

Somers et al. (1992) and the current study used 1-second contraction and 1-second
release and found no change in MAP during exercise testing.
The mechanism by which this contrast occurs is not readily apparent and given
the minimal number of studies it is difficult to attribute attenuation of MAP response with
exercise training to contraction/relaxation speed. However, further study regarding the
effect of contraction/relaxation speed and cardiovascular response to exercise training
is warranted. Therefore, it is difficult to conclusively attribute the differences in the MAP
results to either exercise intensity, exercise session time, or contraction/relaxation
speed. However, the influence of the factors should be further studied.
5.3.4 Limitations
The findings in this study were limited by a number of factors. One such factor
was the difficulty in measuring changes in sympathetic activity in the heart under
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conditions where the heart is experiencing a marked increase in vagal activity. This
factor limited our ability to measure persistent increase in sympathetic activity during
forearm occlusion.

Additionally, resolution of sympathetic activity during forearm

occlusion may further have been limited by the use of a small muscle group during
exercise. It appears that HRV is a suitable measurement of sympathetic activity during
forearm occlusion when the leg muscles are used (Iellamo et al., 2000).
Another limitation was the indication that there is an association between forearm
circumference and cardiovascular control during exercise and post-exercise forearm
occlusion. This finding added significant and previously unappreciated complexity to
the model of post-exercise forearm occlusion. This association also potentially limited
our ability to see training induced changes since not all participants responded in the
same way to exercise.
In addition, it is not clear as to the extent to which environmental factors such as
temperature, relative humidity, and sound contribute to the variability of the parameters
of interest. Moreover seasonal changes in these parameters have not been fully
investigated. As to the former, greater environmental control may eliminate some day to
day variation in parameters. As to the latter, however, it would appear outside of a
yearlong training program, the influence of seasonal variations would be difficult to
exclude.

90

CHAPTER 6 SUMMARY AND CONCLUSIONS
The purpose of this study was twofold: (1) to examine the cardiovascular
response to an acute bout of handgrip exercise in as much as it may be reflective of
stimulation of the EPR; and (2) to evaluate the influence of non-dominant handgrip
exercise training on cardiovascular response to exercise and post-exercise forearm
occlusion. The cardiovascular responses observed in this study were consistent with the
hypothesis that the EPR was stimulated during exercise. However, the resolution of
HRV measurements during post-exercise forearm occlusion was complicated by the
large chronotropic influence of vagal activity on the heart. Uniquely, we found that the
cardiovascular response to exercise and forearm occlusion in a single muscle group is
subject to significant variation in the predominant mechanism of cardiovascular control
despite maneuvers to emphasize a single mechanism.

These findings further

underscore the complexity of studying mechanisms of cardiovascular control in humans.
With respect to the influence of exercise training, we hypothesized that exercise
training would result in attenuated HRV and blood pressure responses to exercise (H60
+50mmHg) and post-exercise forearm occlusion (FAO) in the trained arm. However,
the data do not support this hypothesis. Additionally, we did not see the hypothesized
increase in reactive hyperemic blood flow following exercise training. However, using a
less rigorous statistical test we did see a decrease in forearm vascular resistance during
the reactive hyperemia condition. This finding is in agreement with other studies using
single arm handgrip exercise training and suggests that the training protocol did induce
a physiological adaptation.
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In conclusion, we were successful in using HRV to measure autonomic changes
during exercise.

The failure of HRV to measure persistent sympathetic activity

expected during post-exercise forearm occlusion suggest that HRV may not be a good
tool to use with small muscle exercise in subjects with apparently healthy cardiovascular
control mechanisms. However, it is possible that this model will provide good resolution
during post-exercise forearm occlusion in populations, such as heart failure patients or
the elderly, where autonomic function is compromised.
One very important finding of this study was the association between forearm
circumference and cardiovascular control. This association, particularly during postexercise forearm occlusion, requires further study and possibly requires a re-evaluation
of the cardiovascular control mechanisms involved in post-exercise forearm occlusion.
Although limited, we did see a decrease in vascular resistance in the trained arm
and an increase in endurance time of the training sessions suggesting that a training
effect did occur in our participants. However, the training effect observed could not be
linked to a change in EPR.
Further work needs to be done to more completely characterize EPR
under conditions of exercise and post-exercise forearm occlusion before these
conditions can be used conclusively to indicate changes in EPR both acutely and
chronically. Additionally, the adaptability of the EPR has not been conclusively shown
in either handgrip or leg exercise training and requires further study.

92

REFERENCES
Adreani, C. and M. Kaufman. 1998. Effect of arterial occlusion on responses of group
III and IV afferents to dynamic exercise. Journal of Applied Physiology.
84: 1827-1833.
Adreani, C., J. Hill, and M. Kaufman. 1996. Intrathecal blockade of both NMDA and
non-NMDA receptors attenuates the exercise pressor reflex in cats. Journal
of Applied Physiology. 80: 315-322.
Adreani, C., J. Hill, and M. Kaufman. 1997. Responses of group III and IV muscle
afferents to dynamic exercise. Journal of Applied Physiology. 82: 18111817.
Amara, C. and L. Wolfe. 1998. Reliability of noninvasive methods to measure cardiac
autonomic function. Canadian Journal of Applied Physiology. 23: 396408.
Andres, K., M. von During, and R. Schmidt. 1985. Sensory innervation of the Achilles
tendon by group III and IV afferent fibers. Anatomy and Embryology.
172: 145-156.
Alomari, M., M.Welsch, R. Prisby, C. Lee, R, Wood. 2001. Modification of forearm
vascular fucntion following short-term handgrip exercise training.
International Journal of Sports Medicine. 22: 361-365.
Appelberg, B., M. Hullinger, H. Johansson, and P. Sojka. 1983. Actions on 'motoneurones elicited by electrical stimulation of group III muscle afferent fibres
in the hindlimb of the cat. Journal of Physiology. 335: 275-292.
Bonaduce, D., M. Petretta, V. Cvallaro, C. Apicella, A. Iannicieloo, M. Romano, R.
Breglio, and F. Marciano. 1998. Intensive training and cardiac autonomic control in
high level athletes. Medicine and Science in Sports and Exercise. 30:
691-696.
Bonigut, S., A. Bonham, and C. Stebbins. 1997. Area postrema-induced inhibition of
the exercise pressor reflex. American Journal of Physiology. 272:
H1650-H1655.
Booth, F. and D. Thomason. 1991. Molecular and cellular adaptation of muscle in
response to exercise: Perspectives of various models. Physiological Reviews.
71: 541-584.
Braith, R., M. Welsch, M. Feigenbaum, H. Kluess, and C. Pepine.
Neuroendocrine activation in heart failure is modified by endurance exercise
training. Journal of the American College of Cardiology. 34: 1170-1175.
93

1999.

Brooks, G., T. Fahey, and T. White. 1996. Exercise physiology: Human Bioenergetics
and its applications. 2nd ed. London: Mayfield Publishing
Company.
Cramer, M., K. Beach, D. Strandness. 1983. The detection of proximal deep vein
thrombosis by strain gauge plethysmography through the use of an
outflow/capacitance discriminant line. Bruit. 7: 17-21.
Cooke, W., J. Cox, A. Dietrich, J. Taylor, L. Beightol, J. Ames, J. Hoag, H. Seidel, and
D. Eckberg. 1998. Controlled breathing protocols probe human autonomic
cardiovascular rhythms. American Journal of Physiology. 274: H709-H718.
Darques, J., P. Decherchi, and Y. Jammes. 1998. Mechansims of fatigue-induced
activation of group IV muscle afferents: The roles played by lactic acid
and inflammatory mediators. Neuroscience Letters. 257: 109-112.
de Meersman, R. 1993. Heart rate variability and aerobic fitness. American
Heart Journal. 125: 726-731.
Deligiannis, A., E. Kouidi, and A. Tourkantonis. 1999. Effects of physical training on
heart rate variability in patients on hemodialysis. American Journal of
Cardiology. 84: 197-202.
Dinenno, F., P. Jones, D. Seals, H. Tanaka. 1999. Limb blood flow and vascular
conductance are reduced with age in healthy humans: Relation to elevations in
sympathetic nerve activity and declines in oxygen demand. Circulation. 100:
164-170.
Duru, F., R. Candinas, G. Dziekan, U. Goebbels, J. Myers, and P. Dubach. 2000.
Effect of exercise training on heart rate variability in patients with new-onset left
ventricular dysfunction after myocardial infarction. American Heart
Journal. 140: 157-161.
Dzeka, T., P. Kuzminski, and J. Arnold.
2000.
Venous responsiveness to
norepinephrine in healthy subjects: Effects of single doses of 325 mg aspirin.
Clinical Pharmacology and Therapeutics. 67: 299-304.
Fagraeus, L and D. Linnarsson. 1976. Autonomic origin of heart rate fluctuations at the
onset of muscular exercise. Journal of Applied Physiology.
40:679-682.
Fisher, W. and M. White. 1999. Training-induced adaptations in the central command
and peripheral reflex components of the pressor response to isometric
exercise of the human triceps surae. Journal of Physiology. 520: 621-628.

94

Fontana, G., T. Pantaleo, F. Bongianni, F. Cresci, F. Lavorini, C. Guerra, and P.
Panuccio.
1994.
Prostaglandin synthesis blockade by ketoprofen attenuates
respiratory and cardiovascular responses to static handgrip. Journal of Applied
Physiology. 78: 449-457.
Gonzalez-Camarena, R., S. Carrasco-Sosa, R. Roman-Ramos, M. Gaitan-Gonzalez, V.
Medina-Banuelos, and J. Azpiroz-Leehan. 2000. Effect of static and dynamic exercise
on heart rate and blood pressure variabilities. Medicine
and Science in Sports and Exercise. 32: 1719-1728.
Green, D., T. Cable, C. Fox, J. Rankin, and R. Taylor. 1994. Modification of forearm
resistance vessels by exercise training in young men. Journal of Applied
Physiology. 77: 1829-1833.
Guyton, A. and J. Hall. 2000. Textbook of Medical Physiology. 10th ed.
Philadelphia: W.B. Saunders Co.
Hayward, L., U. Wesselmann, and W. Rymer. 1991. Effect of muscle fatigue on
mechanically sensitive afferents of slow conduction velocity in the cat triceps
surae. Journal of Neurophysiology. 65: 360-370.
Hollander, A. and L. Bouman. 1975. Cardiac acceleration in man elicited by a
muscle-heart reflex. Journal of Applied Physiology. 38: 272-278.
Hull, S., E. Vanoli, P. Adamson, R. Verrier, R. Foreman, and P. Schwartz.
Exercise training confers anticipatory protection from sudden death during acute
myocardial ischemia. Circulation. 89: 548-552.

1994.

Iellamo, F., P. Pizzinelli, M. Massaro, G. Raimondi, G. Peruzzi, J. Legramante. 1999.
Muscle metaboreflex contribution to sinus node regulation during static exercise:
Insights from spectral analysis of heart rate variability. Circulation.
100: 27-32.
Jokkel, G., I. Bonyhay, and M. Kollai. 1995. Heart rate variability after complete
autonomic blockade in man. Journal of the Autonomic Nervous System. 51: 8589.
Kluess, H., R. Wood, D. Stone, and M. Welsch. 2001. Reliability of heart rate variability
during dynamic handgrip exercise. Medicine and Science in Sports
and Exercise. 33: S203, abstract number 1140.
Kluess, H, R. Wood, D. Stone, K. Wilson, M. Welsch. 2002. Vagal modulation and
central hemodynamic response to common doses of orally administered aspirin during
dynamic handgrip exercise and forearm occlusion. Presented at
the SEACSM, Atlanta, GA, January 2002, abstract number O2.

95

Kluess, H., R. Wood, and M. Welsch. 2000. Vagal modulation of the heart and central
hemodynamics during handgrip exercise. American Journal of
Physiology. 279: H1648-H1652.
Kurita, A., B. Takase, H. Hikita, A. Uehata, T. Nishioka, H. Nagayoshi, K. Satomura, and
S. Nakao. 1999. Frequency domain heart rate variability and plasma norepinephrine
level in the coronary sinus during handgrip exercise.
Clinical Cardiology. 22: 207-212.
Laughlin, M., C. Oltman, and D. Bowles. 1998. Exercise training-induced adaptations
in the coronary circulation. Medicine and Science in Sports and
Exercise. 30: 352-360.
Lee, C., N. Aucoin, R. Wood, M. Welsch. 2000. Heart rate variability in Type I
diabetes: Influence of breathing pattern and exercise capacity. Clinical Exercise
Physiology. 2: 72-78.
Lee, C. 2001. Influence of short-term endurance exercise training on heart rate
variability. Dissertation, Louisiana State University, Baton Rouge, Louisiana.
Levy, W., M. Cerqueira, G. Harp, K. Johannessen, I. Abrass, R. Schwartz, and J.
Stratton. 1998. Effect of endurance exercise training on heart rate variability at rest in
healthy young and older men. American Journal of Cardiology. 82:
1236-1241.
Li, J., G. Hand, J. Potts, L. Wilson, and J. Mitchell. 1997. c-Fos expression in the
medulla induced by static muscle contraction in cats. American Journal of
Physiology. 272: H48-H56.
Lombardi, F. 2000. Chaos theory, heart rate variability, and arrhythmic mortality.
Circulation. 101: 8-10.
Machado, B., J.Castania, L. Bonagamba, and H. Salgado. 2000.
Neurotransmission of autonomic components of aortic baroreceptor afferents in
the NTS of awake rats. American Journal of Physiology. 279: H67-H75.
MacLean, D., K. LaNoue, K. Gray, and L. Sinoway. 1998. Effects of hindlimb
contraction on pressor and muscle interstitial metabolite responses in the cat.
Journal of Applied Physiology. 85: 1583-1592.
McClosky, D. and J. Mitchell. 1972. Reflex cardiovascular and respiratory responses
originating in exercising muscle. Journal of Physiology. 224: 173186.
McMahon, S. and P. McWilliam. 1992. Changes in R-R interval at the start of
muscle contraction in the decerebrate cat. Journal of Physiology. 447: 549-562.
96

Mitchell, J., M. Kaufman, and G. Iwamoto. 1983. The exercise pressor reflex: Its
cardiovascular effects, afferent mechanisms, and central pathways. Annual
Reviews in Physiology. 45: 229-242.
Mostoufi-Moab, S., E. Widmaier, J. Cornett, K. Gray, and L. Sinoway. 1998. Forearm
training reduces the exercise pressor reflex during ischemic rhythmic
handgrip. Journal of Applied Physiology. 84: 277-283.
Negrao, C., M. Rondon, T. Tinucci, M. Alves, F. Roveda, A. Braga, S. Reis, L. Nastari,
A. Barretto, E. Krieger, and H. Middlekauff. 2001. Abnormal neurovascular control
during exercise is linked to heart failure severity. American
Journal of Physiology. 280: H1286-H1292.
Ng, A., R. Callister, D. Johnson, and D. Seals. 1994. Endurance exercise training is
associated with elevated basal sympathetic nerve activity in healthy
older humans. Journal of Applied Physiology. 77: 1366-1374.
Notarius, C., D. Atchison, and J. Floras. 2001. Impact of heart failure and exercise
capacity on sympathetic response to handgrip exercise. American
Journal of Physiology. 280: H969-H976.
Paintal, A. 1960. Functional analysis of group III afferent fibers of mammalian
muscles. Journal of Physiology. 152: 250-270.
Pedersen, J., M. Ljubisavljevic, M. Bergenheim, and H. Johansson. 1998. Alterations
in information transmission in ensembles of primary muscle spindle afferents after
muscle fatigue in heteronymous muscle. Neuroscience. 84: 953958.
Peterson, D., R. Armstrong, and M. Laughlin. 1988. Sympathetic neural influences on
muscle blood flow in rats during submaximal exercise. Journal of
Applied Physiology. 65: 434-440.
Piepoli, M., P. Ponikowski, A. Clark, W. Banasiak, A. Capucci, and A. Coats. 1999. A
neural link to explain the "muscle hypothesis" of exercise intolerance in
heart failure. American Heart Journal. 137: 1050-1056.
Potts, J. and J. Mitchell. 1998. Rapid resetting of carotid baroreceptor reflex by afferent
input from skeletal muscle receptors. American Journal of Physiology.
275: H2000-H2008.
Raven, P., J. Potts, X. Shi. 1997. Baroreflex regulation of blood pressure during
dynamic exercise. Exercise and Sport Sciences Reviews. 25: 365-389.

97

Rohrer, T., B. Pfister, and P. Imhof. 1977. The influence of acetylsalicylic acid on
changes in platelet function due to physical exertion. Arzneimittel Forschung:
Drug Research. 27(7): 1490-1493.
Rotto, D. and M. Kaufman. 1988. Effect of metabolic products of muscular contraction
on discharge of group III and IV afferents. Journal of Applied
Physiology. 64: 2306-2313.
Rotto, D., J. Hill, H. Schultz, and M. Kaufman. 1990. Cyclooxygenase blockade
attenuates responses of group IV muscle afferents to static contraction.
American Journal of Physiology. 259: H745-H750.
Rowell, L. 1997. Neural control of muscle blood flow: Importance during dynamic
exercise. Clinical and Experimental Pharmacology and Physiology. 24:
117-125.
Saito, M., S. Iwatse, and T. Mano. 1986. Different responses of muscle sympathetic
nerve activity to sustained and rhythmic handgrip exercises.
Japanese Journal of Physiology. 36: 1053-1057.
Schuit, A., L. van Amelsvoort, T. Verheij, R. Rijneke, A. Maan, C. Swenne, and E.
Schouten. 1999. Exercise Training and heart rate variability in older people.
Medicine and Science in Sports and Exercise. 31: 816-821.
Seals, D. 1989. Sympathetic neural discharge and vascular resistance during
exercise in humans. Journal of Applied Physiology. 66: 2472-2478.
Seals, D. 1993. Influence of active muscle size on sympathetic nerve discharge during
isometric contractions in humans. Journal of Applied Physiology. 75:
1426-1431.
Seals, D. and P. Chase. 1989. Influence of physical training on heart rate variability
and baroreflex circulatory control. Journal of Applied Physiology. 66:
1886-1895.
Seals, D. and R. Victor. 1991 . Regulation of muscle sympathetic nerve activity
during exercise in humans. Exercise and Sport Science Reviews. 19:313-349.
Sinoway, L., J. Hill, J. Pickar, and M. Kaufman. 1993. Effects of contraction and lactic
acid on the discharge of group III muscle afferents in cats. Journal of
Neurophysiology. 69: 1053-1059.
Sinoway, L., J. Shenberger, G. Leaman, R. Zelis, K. Gray, R. Baily, and U.
Leuenberger. 1996. Forearm training attenuates sympathetic responses to prolonged
rhythmic forearm exercise. Journal of Applied Physiology. 81: 17781784.
98

Sinoway, L., J. Shenberger, J. Wilson, D. McLaughlin, T. Musch, and R. Zelis. 1987. A
30-day forearm work protocol increases maximal forearm blood flow.
Journal of Applied Physiology. 62: 1063-1067.
Sinoway, L., K. Wroblewski, S. Prophet, S. Ettinger, K. Gray, S. Whisler, G. Miller, and
R. Moore. 1992. Glycogen depletion-induced lactate reductions attenuate reflex
responses in exercising humans. American Journal of
Physiology. 263: H1499-H1505.
Somers, V., K. Leo, R. Shields, M. Clary, and A. Mark. 1992. Forearm endurance
training attenuates sympathetic nerve response to isometric handgrip
in normal humans. Journal of Applied Physiology. 72: 1039-1043.
Spina, R. 1999. Cardiovascular adaptations to endurance exercise training in
older men and women. Exercise and Sport Sciences Reviews. 27: 317-332.
Stebbins, C. and S. Bonigut. 1996. Endogenous bradykinin in the thoracic spinal cord
contributes to the exercise pressor reflex. Journal of Applied
Physiology. 81; 1288-1294.
Stein, P., A. Ehsani, P. Domitrovich, R. Kleiger, and J. Rottman. 1999. Effect of
exercise training on heart rate variability in healthy older adults. American Heart
Journal. 138: 567-576.
Sterns, D., S. Ettinger, K. Gray, S. Whisler, T. Mosher, M. Smith, and L. Sinoway.
1991. Skeletal muscle metaboreceptor exercise responses are attenuated in
heart failure. Circulation. 84: 2034-2039.
Strange, S. 1999. Cardiovascular control during concomitent dynamic leg exercise and
static arm exercise in humans. Journal of Physiology. 514: 283291.
Sundberg, C. 1994. Exercise and training during graded leg ischaemia in healthy man
with special reference to effects on skeletal muscle. Acta
Physiologica Scandinavica. Supplement: 2-42.
Sverrisdottir, Y., B. Rundqvist, G. Johannsson, and M. Elam. 2000. Sympathetic neural
burst amplitude distribution: A more specific indicator of sympathoexitation
in human heart failure. Circulation. 102: 2076-2081.
Task force of the European Society of Cardiology and the North American Society of
Pacing and Electrophysiology. 1996. Heart rate variability: Standards of measurement,
physiological interpretation, and clinical use. Circulation. 93:
1043-1065.

99

Thomas, G., B. Chavoshan, M. Sander, and R. Victor. 1998. Invited editorial on
:"Effect of arterial occlusion on responses of group III and IV afferents to dynamic
exercise". Journal of Applied Physiology. 84: 1825-1826.
van de Borne, P., N. Montano, B. Zimmerman, M. Pagani, and V. Somers. 1997.
Relationship between repeated measures of hemodynamics, muscle sympathetic
nerve activity, and their spectral oscillations. Circulation. 96: 4326-4332.
Victor, R. and D. Seals. 1989. Reflex stimulation of sympathetic outflow during
rhythmic handgrip exercise in humans. American Journal of Physiology. 257:
H2017-H2024.
Victor, R., D. Seals, and A. Mark. 1987. Differential control of heart rate and
sympathetic nerve activity during dynamic exercise: Insights from intraneural
recordings in humans. Journal of Clinical Investigation. 79: 508-516.
Wilson, L., C. Dyke, D. Parsons, P. Wall, J. Pawelczyk, R. Williams, and J. Mitchell.
1995. Effect of skeletal muscle fiber type on the pressor response evoked by static
contraction in rabbits. Journal of Applied Physiology. 79: 17441752.
Wood, R., S. LeLeux, M. Welsch, A. Nelson, H. Kluess, and A. Lee. 2001. Heart rate
variability following 5 weeks of detraining in competitive swimmers.
Medicina Sportiva. 5: E49-E58.
Zelis, R., L. Sinoway, U. Leuenberger, B. Clemson, and D. Davis. 1991. Time-constant
adaptations in heart failure. European Heart Journal. 12: supplement
C, 2-7.

100

APPENDIX A IRB FOR STUDY
LSU INSTITUTIONAL REVIEW BOARD (IRB)
IRB APPLICATION: APPROVAL OF PROJECTS WHICH USE HUMAN
SUBJECTS
The IRB uses this form to obtain succinct answers to questions it must consider.
If incomplete, your application will be returned! You can download this form and
all other IRB documents from http://www.osr.lsu.edu/osr/irb) & complete it with
your wordprocessor (use Courier 12 and make all margins 0.6" to fit). Call
Dr.Robert C. Mathews for assistance, 578-8692)
=============================================================
=====
(IRB Use: IRB# _____ Review Type: Expedited__ Full ___)
=============================================================
1. Principal Investigator: Robert H. Wood Rank: Ph.D. Dept.: Kinesiology Ph:
(225) 578-9142 E-mail: rwood@lsu.edu SSN (confidential**)121-60-1457
Co-investigators*: Heidi A. Kluess, M.S.
*Student? Y/N __ Thesis/dissertation/class project? Y/N ___
Dept.: Kinesiology

Ph:(225) 578-4983

E-mail:hklues1@lsu.edu
SSN 595-62-7782
2.

(Confidential - For database indexing)**

Project Title: The Effect of a Single Dose of Aspirin on Cardiovascular

Responses During Handgrip Exercise and Forearm Occlusion following 6 weeks
of exercise training
101

3. Proposed duration (months): 12 Start date: September 1, 2001
4. Funding sought from: no funding sought
5. LSU Proposal #: _______ 6. Number of subjects requested: 50

=============================================================
A. ASSURANCE: PRINCIPAL INVESTIGATOR (named above)

I accept personal responsibility for the conduct of this study (including ensuring
compliance of co-investigators/co-workers in accordance with the documents
submitted herewith and the following guidelines for human subject protection:
The Belmont Report, LSU's Assurance with OPRR, and 45 CFR 46 (Available
from OSR or at http://www.osr.lsu.edu/irb/)
Signature of PI ________________________ Date _____________
B. ASSURANCE OF STUDENT/PROJECT COORDINATOR named above
I agree to adhere to the terms of this document and am familiar with the
documents referenced above.
Signature ______________________________ Date ________________
Protocol Abstract
The role of Aspirin in the secondary prevention of myocardial infarction is
well-established (Elwood et al., 1998). The steering committee of the Physician’s
Health Study Research Group (1989) reported a 44% reduction in the risk for
myocardial infarct in individuals randomized to Aspirin. Although the mechanism
for the reduction in risk of myocardial infarct is not entirely understood, Aspirin
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has a powerful antithrombic effect.

Aspirin rapidly inhibits prostaglandin

formation in blood platelets by inactivating fatty acid cyclooxygenase. As a result
of this inhibition, Aspirin prevents the synthesis of thromboxane A2, a
vasoconstrictor and platelet activator. Thus, Aspirin therapy appears to prevent
platelet aggregation and subsequent thrombosis.
However, along with the blockade of platelet cyclooxygenase, Aspirin also
blocks the synthesis of prostaglandins in vascular tissue.

Prostacyclin, a

prostaglandin, is a potent vasodilator and platelet inhibitor.

Aspirin therapy

inactivates platelet cyclooxygenase for the life of the platelets (approximately 1012 days) (Ali, 1995).

In contrast, vascular tissues can resynthesize

cyclooxygenase after exposure to Aspirin, and thus regain the capacity to form
prostaglandins. The ability of vascular tissue to resynthesize cyclooxygenase is,
in part, dependent on the dose of Aspirin administered. Evidence suggests that
Aspirin given in doses less than 325 mg/day is insufficient to block prostaglandin
synthesis (Gajados et al., 1998, Physician’s Health Study Research Group 1989,
Aspirin Myocardial Infarction Study Research Group, 1980). Therefore, vascular
reactivity should be preserved, in contrast to doses exceeding 325 mg/day.
Interestingly, there is some evidence that Aspirin and related non-steriodal antiinflammatory drugs (NSAIDs) in high doses (50 mg per kg of body weight)
attenuates HR and blood pressure responses to exercise by blocking chemically
sensitive receptors in the interstitium of the skeletal muscle (Fontana et al., 1994;
Rotto et al., 1990). Combined, the reduced vascular reactivity and blunted
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hemodynamic response to exercise may result in reduced blood flow to tissue
and subsequently contribute to symptoms of exercise intolerance and fatigue.
In light of these studies, attempts have been made to maximize the
beneficial effects in antithrombic therapy using alternative regimes like low dose
Aspirin, alternate day Aspirin, and control release Aspirin (Physician’s Health
Study Research Group, 1989; Elwood et al., 1998). Interestingly, data is lacking
on the effect of Aspirin therapy on cardiovascular function, such as heart rate,
blood pressure, and blood flow. Knowledge regarding the effects of Aspirin on
cardiovascular function may be clinically useful in further determining the efficacy
in patients with or at risk for occlusive vascular disease. This lab has previously
established a dynamic handgrip exercise protocol through which heart rate and
blood pressure responses are predictable (Kluess et al., 2000) and reliable
(Wood et al., 2000). In Spring 2001 we conducted a study concerning the effect
of a single dose of Aspirin on acute cardiovascular and blood flow response to
exercise. We found that 650 mg of Aspirin decreased heart rate response to
both rest and forearm occlusion, but did not influence blood pressure response or
blood flow.
It is well established that exercise training results in a decrease in both
heart rate and blood pressure response to exercise (Sinoway et al, 1996; Seals
and Chase, 1989; Levy et al., 1998; Fisher and White, 1999; Somers et al, 1992).
However, the mechanisms controlling decreased heart rate and blood pressure
response to exercise are not well understood. To date only one longitudinal study
has been performed to evaluate the role of skeletal muscle afferents in
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cardiovascular control following exercise training (Somers et al., 1992). They
found a significant decrease in sympathetic activity during exercise and forearm
occlusion, but no difference in heart rate and blood pressure response following
low intensity forearm training. Since their exercise training stimulus was below
that which is understood to induce skeletal muscle afferent activity it is possible
their mixed results were due to inadequate training stimulus (Victor and Seals,
1989). Forearm occlusion both during and following exercise is a potent and well
established method to measure the effect of skeletal muscle afferents on
cardiovascular response (Victor, et al., 1987, Somers, 1992, Iellamo, 1999,
Fisher and White, 1999, Victor and Seals, 1989).
Therefore, the purpose of this study is to compare the effect 650-mg of
Aspirin on heart rate, blood pressure, and blood flow responses to rest, handgrip
exercise and recovery during forearm occlusion prior to and following 6 weeks of
exercise training with forearm occlusion.

Such data may provide further

information regarding hear rate and blood pressure control during exercise.
The specific aims of the study are:
1) to determine the effect of 650-mg of Aspirin on cardiovascular response(HR,
BP, and blood flow) to rest, exercise, and recovery during forearm occlusion prior
to exercise training;
2) to determine the effect of 650-mg of Aspirin on cardiovascular response(HR,
BP, and blood flow) to rest, exercise, and recovery during forearm occlusion
following exercise training;
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Participation in this study will not be of any particular benefit to the
participant. Rather, it is the purpose of this investigation to further our knowledge
of how the human body adapts to changes in the environment.
a) A maximum of 50 volunteers over the age of 18 will be asked to
participate in this study. All volunteers will be healthy adults without any over
signs

such

as

diabetes,

heart

disease,

hypertension,

emphysema,

gastrointestinal disturbances or bleeding or gynecological problems. Individuals
with any current medical problems (including those listed above), current
infection, or on medication known to affect cardiovascular function will be
excluded from the study. Additionally, anyone that has taken aspirin within two
weeks prior to testing will be excluded.
b) All participants will receive a comprehensive explanation of the
proposed study, its benefits, inherent risks, and expected commitments with
regard to time. Following explanation of the proposed study, all participants will
be required to read and sign the informed consent document during the first visit
and prior to any experimentation.
Session 1: Informed consent will be obtained from each participant. The
participant will undergo an initial risk screening using the Health Status
Questionnaire that requires the participant to answer questions regarding his
health history and history of physical activity. The participant will be measured
for height and weight. Each participant will be placed in a supine position for 20
minutes prior to evaluation of forearm vascular blood flow.
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Forearm blood flow measurements will be obtained from the dominant arm
using an EC-5R plethysmography system (Hokanson, 1995).

Prior to the

experiment blood pressure cuffs will be positioned around the participant’s upper
arm and wrist, and a mercury-in-silastic strain gauge placed around the forearm
approximately 10 cm distal to the olecranon process.

The forearm will be

extended and slightly supinated and supported by a Styrofoam block.
Immediately before the blood flow measurements, hand circulation will be
occluded for 1 minute by inflating the cuff at the wrist to 240 mmHg. All blood
flow measures will be made with an upper arm venous collecting pressure of 50
mmHg and reported in milliliters per minute per 1000 milliliters of tissue.
Following the resting blood flow measure, the participant will be asked to
perform a handgrip exercise task preceded and followed by quiet rest. The
handgrip exercise tasks consist of squeezing a handgrip measuring device once
every two seconds at less than maximal effort while the cuff on the upper arm is
inflated at 50 mmHg for 5 minutes. Lastly, reactive hyperemia following forearm
occlusion will be achieved by inflating the cuff on the upper arm to 200 mmHg for
3 minutes. Blood flow measures will then be determined as described above.
Throughout the testing procedures, heart rate and blood pressure will be
recorded. The participant will then be allowed to sit up and asked to ingest 650mg of aspirin. One hour after oral administration of Aspirin, the participant will be
asked to repeat the protocol described above using the opposite arm.

The

testing procedures for both arms will last approximately 150 minutes.
Session 2: The participant will arrive at the lab at least 48 hours following session
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1. The protocol for session 1 will be followed except the order of the arms tested
will be
opposite to session 1.
Exercise Training: Participants will report to the laboratory 4 days per week for 6
weeks. The participant will be asked to perform a handgrip exercise to volitional
fatigue. The handgrip exercise task consists of squeezing a handgrip measuring
device once every two seconds at less than maximal effort while the cuff on the
upper arm is inflated at 50 mmHg for 5 minutes. Each training session will last
approximately 30 minutes. Session 3: Following 6 weeks of exercise training the
participants will perform the protocol outlined in session 1.
Session 4: At least 48 hours after session 3, the participants will be asked to
perform the protocol outlined in session 2.
d) There is no risk associated with either the blood flow or exercise testing
involved in this study. However, some participants may experience temporary
discomfort when the blood pressure cuffs are inflated and exercise can result in
muscle soreness, stiffness, or tightness or in some rare cases muscle injury.
There is some risk of gastrointestinal disturbances and bleeding with
administration of Aspirin.

However, in studies that have used 650 mg of

Aspirin/day or less report a very low incidence of adverse events.

(CARS

investigators, 1997).
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GENERAL QUESTIONS:
PROVIDE ANSWERS TO FOLLOWING QUESTIONS. EITHER LOAD INTO
WORDPROCESSOR AND INSERT RESPONSES OR ATTACH SHEETS AND
REFERENCE ALL ITEMS; ANY INAPPLICABLE ITEMS MAY BE SKIPPED
ONLY BY LISTING THE QUESTION LETTER WITH N/A. (BY SIGNATURE,
PAGE 1, YOU ARE ATTESTING TO THE ACCURACY OF THE RESPONSES
TO THESE QUESTIONS.)

A. Why is the use of human subjects necessary (v.s. animals/in vitro)
The question addressed is specific to the value of cardiovascular response in
human participants.
B. Specify sites of data collection.
Data will be collected in room 20 of the Gym Armory and/or room 54 of the Long
Fieldhouse under the direction of Dr. Robert Wood, Assistant Professor, LSU,
Department of Kinesiology.
C. If surgical or invasive procedures are used, give name, address, and
telephone number of supervising physician and the qualifications of the person(s)
performing the procedures. Comparable information when qualified participation
or supervision is required or appropriate.
N/A
D.

Provide the names, dosage, and actions of any drugs or other materials

administered to the subjects and the qualifications of the person(s) administering
the drugs.
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Aspirin 650 mg
E. Detail all the physical, psychological, and social risks to which the subjects
may be exposed.
There are no risks associated with electrocardiography, and non-invasive arterial
tonometry. There are no health risks associated with the evaluation of forearm
blood flow and handgrip exercise, although participants may experience mild
discomfort during either. Lastly, there are minimal risks associated with aspirin
administration.
1) Plethysmography/non-invasive blood flow assessment
There is no risk associated with venous occlusion plethysmography. However,
participants may experience some temporary discomfort during the five minutes
of forearm occlusion as a result of the 240 mmHg applied to the upper arm.
Should the participant ask to discontinue this procedure then the upper-arm cuff
will be deflated immediately.
2) Handgrip exercise
Because of the small amount of muscle mass involved in this type of exercise,
the typical cardiovascular responses involve a modest increase in HR,
suggesting that this activity is of no greater than moderate in intensity, and
therefore it is appropriate for all individuals, and poses extremely low health risk
for the study sample. Handgrip exercise applied according to the methods
described may result in mild muscle soreness, muscle stiffness, or tightness, or
in some rare cases muscle injury.
3) Aspirin Administration
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Although rare, allergic reaction may occur with a single dose of aspirin. While,
chronic use of Aspirin at 650 mg or less, can result in gastrointestinal
disturbances and bleeding (0.74 events per 100 people studied). As is the case
in this study, the incidence of such adverse reactions is even less in studies with
short-term exposure (CARS investigators, 1997).
F. What steps will be taken to minimize risks to subjects?
The risk associated with handgrip is extremely low, nonetheless proper patient
screening careful exercise prescription, and appropriate assessment of exercise
response will ensure that the risks are kept minimal. In addition, the investigator
will have graduate level training in clinical exercise physiology and will possess
current CPR certification. The risk associated with aspirin administration will be
minimized by careful evaluation of Aspirin sensitivity while recruiting subjects.
Additionally, anyone that has taken aspirin within two weeks prior to testing will
be excluded.
G. Describe the recruitment pool (community, institution, group) and the criteria
used to select and exclude subjects.
Participants for this study will be recruited from undergraduate and graduate
courses in the LSU department of Kinesiology. A total of 50 volunteers over the
age of 18 will be asked to participate in this study. All volunteers will be healthy
adults without any overt signs such as asthma, diabetes, heart disease,
hypertension, emphysema, gastrointestinal disturbances or bleeding, known
allergy to Aspirin, or gynecological problems.

Individuals with any current

medical problems (including those listed above), current infection, or on
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medication known to affect cardiovascular function will be excluded from the
study.
H.List any vulnerable population whose members are included in this
project (e.g., children under the age of 18; mentally impairedpersons; pregnant
women; prisoners; the aged.)
High risk individuals (as defined above) will be excluded from participation in this
study.
I.

Describe

the

process

through

which

informed

consent

will

be

obtained.(Informed consent usually requires an oral explanation, discussion, and
opportunity for questions before seeking consent form signature.)
All participants will receive a comprehensive explanation of the proposed study,
its benefits, inherent risks, and expected time commitments.

Following the

explanation of the proposed protocol, all participants will be allowed a period of
questioning. Individuals who are willing to participate in the study will be required
to read and sign the informed consent document during the first visit. Each
participant will receive a copy of the informed consent form.
J. (1) Is this study anonymous or confidential? (Anonymous means that the
identity of the subjects is never linked to the data, directly, or indirectly through a
code system.) (2) If a confidential study, detail how will the privacy of the subjects
and security of their data will be protected.
There is no conflict of interest for the investigators in this protocol. The only
potential gain to the investigators is the professional benefit from academic
publication or presentation of the results. The names and personal information of
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each participant will not appear in print or will be presented in a manner that
would not identify the individual.

All documents containing confidential

information will be kept in a locked cabinet in a locked laboratory. Only members
of the research team whose names are indicated herein will be granted access to
these records.
CONSENT FORM
1. Study Title: The Effect of a Single Dose of Aspirin on Cardiovascular
Responses During Handgrip Exercise and Forearm Occlusion Following 6
Weeks of Exercise Training
2. Performance Site:
3. Investigators:

Department of Kinesiology, Louisiana State University

The following investigators are available for questions at the

telephone numbers listed below:
Principal Investigator:
Robert H. Wood, Ph.D.
Department of Kinesiology (225) 578-9142
Co-Investigators:
Heidi A. Kluess, M.S.
Department of Kinesiology (225) 578-2036
4. Purpose of the Study: The purpose of this study is to compare the effect one
dose of Aspirin on heart rate, blood pressure, and blood flow during: 1) rest, 2)
less than maximal muscular effort, and 3) during inflation of a blood pressure cuff
on the participant's upper arm to 240 mmHg for 2 minutes. These measures will
be made before and after 6-weeks of arm exercise.
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5. Participant Inclusions: A total of 50 volunteers over the age of 18 will be asked
to participate in this study. All volunteers will be healthy adults without any over
signs such as diabetes, heart disease, high blood pressure, lung disease,
digestive disturbances or bleeding, or female reproductive problems.
6. Participant exclusions: Individuals with any current medical problems
(including those listed above), current infection, or on medication known to affect
heart or blood vessels will be excluded from the study. Additionally, anyone that
has taken aspirin within two weeks prior to testing will be excluded.
7. Description of the Study: The proposed study consists of 4 separate visits to
the laboratory over a 4-month period and 24 sessions of exercise training. Each
visit is expected to last approximately 2.5 hours.

After informed consent is

obtained, the participant will be asked to answer questions regarding his health
history, history of physical activity, and will be measured for height and weight.
Pre-test Session 1: Each participant will be placed in a supine position and asked
to squeeze a handgrip-measuring device as tightly as possible. Following 20
minutes of quiet rest, forearm blood flow measurements will be obtained. Prior to
the experiment blood pressure cuffs will be positioned around the participant's
upper arm and wrist, and a band placed around the forearm to measure blood
flow. Before blood flow measurements are taken, the blood pressure cuff on the
wrist will be inflated to 240 mmHg for 1 minute. Following this, the upper arm
cuff will be inflated to 50 mmHg for approximately 10 seconds and a blood flow
measurement taken.
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Following 5 minutes of quiet rest, the cuff on the participants upper arm
will be inflated to 50 mmHg and they will be asked to perform a handgrip exercise
task consisting of squeezing the hand grip measuring device once every two
seconds at less than maximal effort to fatigue. Immediately following the
handgrip exercise bout, the cuff on the upper arm will be inflated to 200 mmHg
for 2 minutes. Blood flow measures will then be determined as described above.
During rest, the performance of the handgrip exercise task, and forearm
occlusion the measurements of heart rate, heart rhythm, and blood pressure will
be obtained using a blood pressure measuring device on the wrist.

The

participant will then be asked to ingest 650 mg of Aspirin. Following one hour of
quiet rest, the opposite arm of the participant will be testing using the protocol
described above. The testing procedures will last approximately 150 minutes.
Pre-test Session 2: The heart rate, blood pressure, and blood flow responses to
handgrip exercise and cuff inflation will be tested using the protocol described in
session 1, but the order of the arms tested will be opposite to session 1.
Exercise training: Participants will be asked to perform 16 sessions of handgrip
exercise training over a 6-week period. The participant will be asked to perform a
handgrip exercise task consisting of squeezing the hand grip measuring device
once every two seconds at less than maximal effort while the cuff on the upper
arm is inflated to 50 mmHg. Each session will last approximately 30 minutes.
Post test Session 3 and 4: Following 6 weeks of exercise training, participants
will be tested using the protocol outlined in sessions 1 and 2 above.
8. Benefits: Participation in this study will not be of any particular benefit to the
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participant. Rather, it is the purpose of this investigation to further our knowledge
of how the human body adapts to changes in the environment.
9. Risks: There are no known risks associated with obtaining heart rate, heart
rhythm, and blood pressure. The risks associated with this protocol can be
broken down into risk associated with the evaluation of forearm blood flow, the
handgrip exercise testing component, and Aspirin administration.
a) Plethysmography/Non-invasive blood flow assessment
There is no health risk associated with the procedures involved in this study.
However, participants may experience some temporary discomfort when the
blood pressure cuff is inflated prior to the measurement of forearm blood flow.
b) Handgrip exercise testing and training
The risk of handgrip exercise testing using the methods described are minimal in
this population, but include muscle soreness, muscle stiffness or tightness, or in
some rare cases muscle injury. The risk of this study will be minimized as a
result of proper evaluation, education, and treatment, careful handgrip exercise
prescription, and appropriate assessment of handgrip exercise responses, the
presence of well trained personnel capable of monitoring handgrip exercise
equipment, and a person trained in CPR available while subjects are being
tested.
c) Aspirin administration
Although rare, allergic reaction may occur with a single dose of Aspirin. Regular
use of Aspirin can result in digestive disturbances and bleeding.

However,

studies that have used daily doses of 650 mg of Aspirin or less report a very low
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chance of allergic reaction and digestive disturbances (0.74 events per 100
people studied). The incidence of reactions to Aspirin is even less in studies with
short-term exposure.
10. Right to refuse: Participation in this study is completely voluntary and
participants may withdraw at any time without penalty.
11. Privacy: Though the results of this study may be published, the privacy of the
participants will be protected and their identities will remain confidential.
12. Release of Information: The records for each participant in this study may be
reviewed by investigators, but participant identity will be kept confidential. The
data collected will only be used for purposes stated in this consent form.
13. Financial Information: There is no monetary cost to participate in this study
nor will any payment be rendered to participants. The study has been discussed
with me and all my questions have been answered. I may direct additional
questions regarding study specifics to the investigators. If I have questions about
subjects' rights or other concerns, I can contact Robert C. Mathews, Chairman,
LSU Institutional Review Board, (225)388-8692. I agree to participate in the study
described above and acknowledge the researchers obligation to provide me with
a copy of this consent form if signed by me.
_________________________

________________

Participant’s signature
_________________________

date
________________

Witness signature
_________________________

date
________________
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Investigator’s signature

date
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APPENDIX B MEDICAL HISTORY QUESTIONNAIRE
Fall 2001
Participant Medical History

The effect of a single dose of aspirin on cardiovascular responses during
handgrip exercise and forearm occlusion on 4 weeks of exercise training

Name : ______________________

Date: ____________

_______________ Age: _________ Gender: Male
Cauc. Afr.Am

other ___________

Height: _______

Weight: ________

Female

Phone number:
Race:

Has the participant ever been diagnosed with:
Yes

No

Hypertension

____

____

Diabetes

____

____

Emphysema

____

____

Asthma

____

____

Hyperlipidemia

____

____

Epilepsy

____

____

Heart Failure

____

____

Osteoarthritis

____

____

CVD
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Rheumatoid Arthritis

____

____
Peripheral Vascular Disease

____

____
Anemia

____

Signs or symptoms of hypoglycemia

____
____

____
Surgery on arms or hands

____

____

24 Hour History:
How much sleep did you get last night? (Please circle one)
1

2

3

4

5

6

7

8

9

10

9

10

(Hours)

How much sleep do you normally get? (Please circle one)
1

2

3

4

5

6

7

8

(Hours)
When did you last have:
A cup of coffee or tea
Eat food

_________________________
_________________________

Smoke a cigarette, cigar, or pipe _________________________
Aspirin, ibuprofen, or other drugs _________________________
Drink alcohol

_________________________
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Any recent illness

_________________________

Exercise

_________________________

Describe your general feelings today. (Circle one)

Excellent

Very

Good
Neither bad nor good

Bad

Very bad
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Very, very bad

Terrible

Good

APPENDIX C SUPPLEMENTAL DIAGRAMS FOR METHODS
Diagram C.1: Set up for pre- and post- testing

Plethysmograph

Colin BP monitor

Biodex with
Handgrip
dynamometer

ECG monitor

Pneumotachometer
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Diagram C.2: Data collection time line
20 min
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Set up arm 1
3 min

Blood
Forearm occlusion

measurement
Blood

5 min

Continuous ECG

5 min

Spontaneous

60%resting

flow

flow

measurement
MVC

Handgrip exercise +
and BP
measurement

3 min

Forearm Occlusion
Blood

flow

measurement
Resting MVC
Set up arm 2
equipment
3 min

Blood
Forearm occlusion

measurement
Blood

5 min

Spontaneous

5 min

60%resting

MVC

Handgrip exercise +

measurement
3 min

Forearm Occlusion
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flow

measurement

Continuous ECG
and BP

flow

Systolic

Blood

pressure

Mean Arterial
Pressure

Diastolic

Blood

pressure
Diagram C.3: Example of blood pressure wave with labels for systolic and
diastolic blood pressure
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Change in mean R-R from SB1 to H60+50mmHg

APPENDIX D FIGURES FOR THE INDIVIDUAL RESPONSES IN THE
TRAINING GROUP IN THE NON-DOMINANT ARM DURING H60+50MMHG
AND FAO PRE-TRAINING AND POST TRAINING FOR MEAN R-R, LFNU, AND
MAP

pre

post

0
-100
-200
-300
-400
-500
-600
-700
Figure D.1: Individual responses for the change in mean R-R
(msec) from SB1 to H60+50mmHg before (pre) and after (post)
training in the non-dominant arm of the training group . The
bold line indicates the mean of the group.
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Change in mean R-R from SB1 to FAO (ms)
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-100
Figure D.2: Individual responses for the change in mean R-R
from SB1 to FAO before (pre) and after (post) training in the
non-dominant arm of the training group . The bold line
indicates the mean of the group.
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post
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Figure D.3: Individual responses for the change in LFnu from
SB1 to H60+50mmHg before (pre) and after (post) training in
the non-dominant arm of the training group . The bold line
indicates the mean of the group.
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Figure D.4: Individual responses for the change in LFnu from
SB1 to FAO before (pre) and after (post) training in the nondominant arm of the training group . The bold line indicates the
mean of the group.
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Figure D.5: Individual responses for the change in MAP from
SB1 to H60+50mmHg before (pre) and after (post) training in
the non-dominant arm of the training group . The bold line
indicates the mean of the group.
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Change in MAP from SB1 to FAO (mmHg)

pre

post

40
20
0
-20
-40
-60
-80
-100
Figure D.6: Individual responses for the change in MAP from
SB1 to FAO before (pre) and after (post) training in the nondominant arm of the training group . The bold line indicates the
mean of the group.
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APPENDIX E ABSOLUTE VALUES FOR POST-TEST
Table E.1: The effect of condition on respiratory rate by group and arm (post-test
only).
Respiratory
rate External control
Trained (n=17)
Internal control
(breaths/min)

(n=14)

Non-dominant

Non-dominant

(n=17)
Dominant

SB1

16.79±2.83

16.59±3.59

16.11±3.97

H60+50mmHg

20.29±5.59

20.59±5.95*

19.88±5.36*

FAO

14.71±5.36H

15.00±4.35H

15.33±3.50H

Mean±standard deviation
H different from H60+50mmHg
* different from SB1
Table E.2: The effect of condition on mean R-R by group and arm (post-test
only).
Mean R-R (miliseconds)
External control
Trained (n=19)
Internal control
(n=15)

Non-dominant

Non-dominant

(n=19)
Dominant

SB1

972.62±122.56

980.95±190.20

998.76±178.86

H60+50mmHg

751.29±85.10*

744.77±114.95*

775.23±95.36*

FAO

912.88±149.68H

897.51±144.80H

948.34±150.79H

Mean±standard deviation
H different from H60+50mmHg
* different from SB1
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Table E.3: The effect of condition on SDNN by group and arm (post-test only).
SDNN (miliseconds)
External control
Trained (n=19)
Internal control
(n=15)

Non-dominant

Non-dominant

(n=19)
Dominant

SB1

101.44±46.76

87.76±36.77

103.21±47.28

H60+50mmHg

49.01±25.83

46.76±40.14*

53.61±35.36*

FAO

103.83±71.10

96.99±47.85H

102.84±52.98H

Mean±standard deviation
H different from H60+50mmHg
* different from SB1
Table E.4: The effect of condition on LFnu by group and arm (post-test only).
LFnu (%)
External control
Trained (n=19)
Internal control
(n=15)

Non-dominant

Non-dominant

(n=19)
Dominant

SB1

56.34±16.57

55.44±22.46

61.89±19.49

H60+50mmHg

69.91±20.61

76.18±13.33*

70.55±16.18*

FAO

57.95±20.62

61.60±17.50H

51.55±17.10H

Mean±standard deviation
H different from H60
* different from SB1

132

Table E.5: The effect of condition on MAP by group and arm (post-test only).
MAP (mmHg)
External control
Trained (n=19)
Internal control
(n=14)

Non-dominant

Non-dominant

(n=16)
Dominant

SB1

80.08±8.72

78.27±20.95

78.41±12.26

H60+50mmHg

97.55±14.40*

97.69±23.63*

92.85±13.67*

FAO

95.17±14.27*

92.33±29.14*

91.44±17.28*

Mean±standard deviation
H different from H60+50mmHg
* different from SB1
Table E.6: The effect of condition on SBP by group and arm (post-test only).
SBP (mmHg)
External control
Trained (n=16)
Internal control
(n=14)

Non-dominant

Non-dominant

(n=16)
Dominant

SB1

121.67±19.69

123.11±19.27

113.48±16.07

H60+50mmHg

135.11±22.07

136.75±23.06*

129.58±19.59*

FAO

132.52±23.06

132.10±31.21

126.65±26.47

Mean±standard deviation
H different from H60+50mmHg
* different from SB1
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Table E.7: The effect of condition on DBP by group and arm (post-test only).
DBP (mmHg)
External control
Trained (n=18)
Internal control
(n=14)

Non-dominant

Non-dominant

(n=16)
Dominant

SB1

69.44±20.33

62.86±19.77

62.56±16.41

H60+50mmHg

80.73±13.55

80.24±22.95*

77.00±13.20*

FAO

78.52±15.47

70.65±28.17

72.23±16.39

Mean±standard deviation
H different from H60+50mmHg
* different from SB1
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APPENDIX F POST HOC POWER ANALYSIS
Table F.1: Mean , standard deviation, confidence interval, and type II error rate for MAP during
)H60+50mmHg
Group
Treatment
95%
95%
Mean
Standard error

External

confidence

confidence

interval

interval

Low

High

pre

28.85

5.63

17.34

40.35

post

17.47

3.61

10.09

24.84

Training

pre

18.17

5.01

7.72

28.61

Training

post

19.21

3.27

12.51

25.90

Control
External
Control

Type II error rate for the interaction of Treatment by group = 0.347
Type II error rate for the main effect of Treatment = 0.256
Type II error rate for the main effect of Group = 0.136
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Table F.2: Mean , standard deviation, confidence interval, and type II error rate for MAP during
)FAO
Group
Treatment
95%
95%
Mean
Standard error

External

confidence

confidence

interval

interval

Low

High

pre

16.48

5.76

4.70

28.27

post

15.09

4.67

5.55

24.64

Training

pre

17.82

5.23

7.12

28.51

Training

post

15.30

4.24

6.64

23.96

Control
External
Control

Type II error rate for the interaction of Treatment by group = 0.052
Type II error rate for the main effect of Treatment = 0.077
Type II error rate for the main effect of Group = 0.052
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Table F.3: Mean , standard deviation, confidence interval, and type II error rate for LFnu during
)H60+50mmHg
Group
Treatment
95%
95%
Mean
Standard error

External

confidence

confidence

interval

interval

Low

High

pre

16.83

4.42

7.80

25.86

post

13.32

5.72

1.63

25.01

Training

pre

20.00

3.51

12.82

27.17

Training

post

20.74

4.54

11.45

30.03

Control
External
Control

Type II error rate for the interaction of Treatment by group = 0.072
Type II error rate for the main effect of Treatment = 0.059
Type II error rate for the main effect of Group = 0.204
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Table F.4: Mean, standard deviation, confidence interval, and type II error rate for LFnu during
∆FAO
Group
Treatment
Mean
Standard error
95%
95%

External

confidence

confidence

interval

interval

Low

High

pre

8.43

4.86

-1.50

18.36

post

-0.01

4.97

-10.25

10.06

Training

pre

-7.26

4.02

-15.47

0.96

Training

post

-6.16

4.11

-14.56

2.24

Control
External
Control

Type II error rate for the interaction of Treatment by group = 0.251
Type II error rate for the main effect of Treatment = 0.168
Type II error rate for the main effect of Group = 0.517
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